Wytyczne ESC dotyczące rozpoznawania i leczenia chorób tętnic obwodowych w 2017 roku, przygotowane we współpracy z ESVS.
Alternative titles :
[en] 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
Tendera M, Aboyans V, Bartelink ML, et al.ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: The Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC).Eur Heart J.2011; 32(22): 2851-2906, doi: 10.1093/eurheartj/ehr211.
Fowkes FG, Rudan D, Rudan I, et al.Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis.Lancet.2013; 382(9901): 1329-1340, doi: 10.1016/S0140-6736(13)61249-0, indexed in Pubmed: 23915883.
Belcaro G, Nicolaides AN, Ramaswami G, et al.Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: A 10-year follow-up study (the CAFES-CAVE study(1)).Atherosclerosis.2001; 156(2): 379-387, indexed in Pubmed: 11395035.
Giannopoulos A, Kakkos S, Abbott A, et al.Long-term Mortality in Patients with Asymptomatic Carotid Stenosis: Implications for Statin Therapy.Eur J Vasc Endovasc Surg.2015; 50(5): 573-582, doi: 10.1016/j.ejvs.2015.06.115, indexed in Pubmed: 26299982.
Criqui MH, Aboyans V.Epidemiology of peripheral artery disease.Circ Res.2015; 116(9): 1509-1526, doi: 10.1161/CIRCRESAHA.116.303849, indexed in Pubmed: 25908725.
Fowkes FGR, Murray GD, Butcher I, et al.Ankle Brachial Index Collaboration.Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: A meta-analysis.JAMA.2008; 300(2): 197-208, doi: 10.1001/jama.300.2.197, indexed in Pubmed: 18612117.
Weitz JI, Byrne J, Clagett GP, et al.Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: A critical review.Circulation.1996; 94(11): 3026-3049, indexed in Pubmed: 8941154.
Valentine RJ, Guerra R, Stephan P, et al.Family history is a major determinant of subclinical peripheral arterial disease in young adults.J Vasc Surg.2004; 39(2): 351-356, doi: 10.1016/j.jvs.2003.07.011, indexed in Pubmed: 14743135.
Wassel CL, Loomba R, Ix JH, et al.Family history of peripheral artery disease is associated with prevalence and severity of peripheral artery disease: The San Diego population study.J Am Coll Cardiol.2011; 58(13): 1386-1392, doi: 10.1016/j.jacc.2011.06.023, indexed in Pubmed: 21920269.
Khaleghi M, Isseh IN, Bailey KR, et al.Family history as a risk factor for peripheral arterial disease.Am J Cardiol.2014; 114(6): 928-932, doi: 10.1016/j.amjcard.2014.06.029, indexed in Pubmed: 25107577.
Corrà U, Piepoli MF, Carré F, et al.European Association of Cardiovascular Prevention and Rehabilitation Committee for Science Guidelines, EACPR, Document Reviewers.Secondary prevention through cardiac rehabilitation: Physical activity counselling and exercise training: Key components of the position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation.Eur Heart J.2010; 31(16): 1967-1974, doi: 10.1093/eurheartj/ehq236, indexed in Pubmed: 20643803.
Craig CL, Marshall AL, Sjöström M, et al.International physical activity questionnaire: 12-country reliability and validity.Med Sci Sports Exerc.2003; 35(8): 1381-1395, doi: 10.1249/01.
Washburn RA, Smith KW, Jette AM, et al.The Physical Activity Scale for the Elderly (PASE): Development and evaluation.J Clin Epidemiol.1993; 46(2): 153-162, indexed in Pubmed: 8437031.
Pickett CA, Jackson JL, Hemann BA, et al.Carotid bruits as a prognostic indicator of cardiovascular death and myocardial infarction: A meta-analysis.Lancet.2008; 371(9624): 1587-1594, doi: 10.1016/S0140-6736(08)60691-1, indexed in Pubmed: 18468542.
Clark CE, Taylor RS, Shore AC, et al.Association of a difference in systolic blood pressure between arms with vascular disease and mortality: A systematic review and meta-analysis.Lancet.2012; 379(9819): 905-914, doi: 10.1016/S0140-6736(11)61710-8, indexed in Pubmed: 22293369.
Cournot M, Taraszkiewicz D, Cambou JP, et al.Additional prognostic value of physical examination, exercise testing, and arterial ultrasonography for coronary risk assessment in primary prevention.Am Heart J.2009; 158(5): 845-851, doi: 10.1016/j.ahj.2009.08.017, indexed in Pubmed: 19853707.
Vlachopoulos C, Xaplanteris P, Aboyans V, et al.The role of vascular biomarkers for primary and secondary prevention.A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society.Atherosclerosis.2015; 241(2): 507-532, doi: 10.1016/j.atherosclerosis.2015.05.007, indexed in Pubmed: 26117398.
Criqui MH, McClelland RL, McDermott MM, et al.The ankle- -brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis).J Am Coll Cardiol.2010; 56(18): 1506-1512, doi: 10.1016/j.jacc.2010.04.060, indexed in Pubmed: 20951328.
Wu MY, Hsiang HF, Wong CS, et al.The effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography: A meta- -analysis of randomized controlled trials.Int Urol Nephrol.2013; 45(5): 1309-1318, doi: 10.1007/s11255-012-0363-1, indexed in Pubmed: 23283594.
O'Sullivan S, Healy DA, Moloney MC, et al.The role of N-acetylcysteine in the prevention of contrast-induced nephropathy in patients undergoing peripheral angiography: A structured review and meta-analysis.Angiology.2013; 64(8): 576-582, doi: 10.1177/0003319712467223, indexed in Pubmed: 23188834.
Merten GJ, Burgess WP, Gray LV, et al.Prevention of contrast- -induced nephropathy with sodium bicarbonate: A randomized controlled trial.JAMA.2004; 291(19): 2328-2334, doi: 10.1001/jama.291.19.2328, indexed in Pubmed: 15150204.
Akyuz S, Yaylak B, Altay S, et al.The Role of Statins in Preventing Contrast-Induced Acute Kidney Injury: A Narrative Review.Angiology.2015; 66(8): 701-707, doi: 10.1177/0003319714549556, indexed in Pubmed: 25192700.
Ramalho J, Semelka RC, Ramalho M, et al.Gadolinium-Based Contrast Agent Accumulation and Toxicity: An Update.AJNR Am J Neuroradiol.2016; 37(7): 1192-1198, doi: 10.3174/ajnr.A4615, indexed in Pubmed: 26659341.
Graham I, Atar D, Borch-Johnsen K, et al.European guidelines on cardiovascular disease prevention in clinical practice: Executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).Eur Heart J.2007; 28: 2375-2414.
Piepoli MF, Hoes AW, Agewall S, et al.Authors/Task Force Members:, Authors/Task Force Members, Additional Contributor: Simone Binno (Italy), Document Reviewers:, Authors/Task Force Members.2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).Eur Heart J.2016; 37(29): 2315-2381, doi: 10.1093/eurheartj/ehw106, indexed in Pubmed: 27222591.
Rydén L, Grant PJ, Anker SD, et al.Authors/Task Force Members, ESC Committee for Practice Guidelines (CPG), Document Reviewers.ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).Eur Heart J.2013; 34(39): 3035-3087, doi: 10.1093/eurheartj/eht108, indexed in Pubmed: 23996285.
Bullen C.Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease.Expert Rev Cardiovasc Ther.2008; 6(6): 883-895, doi: 10.1586/14779072.6.6.883, indexed in Pubmed: 18570625.
Lim S, Vos T, Flaxman A, et al.A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010.Lancet.2012; 380(9859): 2224-2260, doi: 10.1016/s0140-6736(12)61766-8.
Morris PB, Ference BA, Jahangir E, et al.Cardiovascular Effects of Exposure to Cigarette Smoke and Electronic Cigarettes: Clinical Perspectives From the Prevention of Cardiovascular Disease Section Leadership Council and Early Career Councils of the American College of Cardiology.J Am Coll Cardiol.2015; 66(12): 1378-1391, doi: 10.1016/j.jacc.2015.07.037, indexed in Pubmed: 26383726.
Aung PP, Maxwell HG, Jepson RG, et al.Lipid-lowering for peripheral arterial disease of the lower limb.Cochrane Database Syst Rev.2007(4): CD000123, doi: 10.1002/14651858.CD000123.pub2, indexed in Pubmed: 17943736.
Antoniou GA, Fisher RK, Georgiadis GS, et al.Statin therapy in lower limb peripheral arterial disease: Systematic review and meta- Analysis.Vascul Pharmacol.2014; 63(2): 79-87, doi: 10.1016/j.vph.2014.09.001, indexed in Pubmed: 25446168.
Heart Protection Study Collaborative Group.Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions.J Vasc Surg.2007; 45(4): 645-654; discussion 653, doi: 10.1016/j.jvs.2006.12.054, indexed in Pubmed: 17398372.
Kumbhani DJ, Steg PhG, Cannon CP, et al.REACH Registry Investigators.Statin therapy and long-term adverse limb outcomes in patients with peripheral artery disease: Insights from the REACH registry.Eur Heart J.2014; 35(41): 2864-2872, doi: 10.1093/eurheartj/ehu080, indexed in Pubmed: 24585266.
Westin GG, Armstrong EJ, Bang H, et al.Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia.J Am Coll Cardiol.2014; 63(7): 682-690, doi: 10.1016/j.jacc.2013.09.073, indexed in Pubmed: 24315911.
Murphy SA, Cannon CP, Blazing MA, et al.Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.J Am Coll Cardiol.2016; 67(4): 353-361, doi: 10.1016/j.jacc.2015.10.077, indexed in Pubmed: 26821621.
Meade T, Zuhrie R, Cook C, et al.Bezafibrate in men with lower extremity arterial disease: Randomised controlled trial.BMJ.2002; 325(7373): 1139, indexed in Pubmed: 12433762.
Amarenco P, Labreuche J, Lavallée P, et al.Statins in stroke prevention and carotid atherosclerosis: Systematic review and up-to-date meta-analysis.Stroke.2004; 35(12): 2902-2909, doi: 10.1161/01.
Huang Y, Li W, Dong L, et al.Effect of statin therapy on the progression of common carotid artery intima-media thickness: An updated systematic review and meta-analysis of randomized controlled trials.J Atheroscler Thromb.2013; 20(1): 108-121, indexed in Pubmed: 23095240.
Sabatine MS, Giugliano RP, Keech AC, et al.FOURIER Steering Committee and Investigators.Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.N Engl J Med.2017; 376(18): 1713-1722, doi: 10.1056/NEJMoa1615664, indexed in Pubmed: 28304224.
Staessen JA, Thijs L, Celis H, et al.Systolic Hypertension in Europe Trial Investigators (the Syst-Eur Trial), Systolic Hypertension in Europe Trial Investigators.Treatment of isolated systolic hypertension in the elderly: Further evidence from the systolic hypertension in Europe (Syst-Eur) trial.Am J Cardiol.1998; 82(9B): 20R-22R, indexed in Pubmed: 9822139.
Mancia G, Fagard R, Narkiewicz K, et al.Task Force Members.2013 ESH/ESC Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).J Hypertens.2013; 31(7): 1281-1357, doi: 10.1097/01.hjh.0000431740.32696.cc, indexed in Pubmed: 23817082.
Bavry AA, Anderson RD, Gong Y, et al.Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: Findings from the INternational VErapamil-SR/Trandolapril STudy.Hypertension.2010; 55(1): 48-53, doi: 10.1161/HYPERTENSIONAHA.109.142240, indexed in Pubmed: 19996066.
Wright JT, Williamson JD, Whelton PK, et al.A Randomized Trial of Intensive versus Standard Blood-Pressure Control.N Eng J Med.2015; 373(22): 2103-2116, doi: 10.1056/nejmoa1511939.
Cushman WC, Whelton PK, Fine LJ, et al.SPRINT Study Research Group.SPRINT Trial Results: Latest News in Hypertension Management.Hypertension.2016; 67(2): 263-265, doi: 10.1161/HYPERTENSIONAHA.115.06722, indexed in Pubmed: 26553234.
Guideline: Sodium intake for adults and children.World Health Organisation, Geneva 2014.
Yusuf S, Sleight P, Pogue J, et al.Heart Outcomes Prevention Evaluation Study Investigators.Effects of an angiotensin-converting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.N Engl J Med.2000; 342(3): 145-153, doi: 10.1056/NEJM200001203420301, indexed in Pubmed: 10639539.
Böhm M, Schumacher H, Teo KK, et al.Telmisartan, ramipril, or both in patients at high risk for vascular events.N Engl J Med.2008; 358(15): 1547-1559, doi: 10.1056/NEJMoa0801317, indexed in Pubmed: 18378520.
Armstrong EJ, Chen DC, Singh GD, et al.Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia.Vasc Med.2015; 20(3): 237-244, doi: 10.1177/1358863X15574321, indexed in Pubmed: 25835349.
Paravastu SC, Mendonca DA, Da Silva A, et al.Beta blockers for peripheral arterial disease.Eur J Vasc Endovasc Surg.2009; 38(1): 66-70, doi: 10.1016/j.ejvs.2009.02.019, indexed in Pubmed: 19359199.
Aronow WS, Ahn C.Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease.Am J Cardiol.2001; 87(11): 1284-1286, indexed in Pubmed: 11377356.
CAPRIE Steering Committee.A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).CAPRIE Steering Committee.Lancet.1996; 348(9038): 1329-1339, indexed in Pubmed: 8918275.
Law MR, Morris JK, Wald NJ.Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies.BMJ.2009; 338: B1665, indexed in Pubmed: 19454737.
Ostergren J, Sleight P, Dagenais G, et al.Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease.Eur Heart J.2004; 25(1): 17-24, indexed in Pubmed: 14683738.
Antithrombotic Trialists' Collaboration.Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.BMJ.2002; 324(7329): 71-86, doi: 10.1136/bmj.324.7329.71.
Diener HC, Sacco RL, Yusuf S, et al.Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) study group, PRoFESS Study Group.Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke.N Engl J Med.2008; 359(12): 1238-1251, doi: 10.1056/NEJMoa0805002, indexed in Pubmed: 18753638.
Bhatt DL, Flather MD, Hacke W, et al.CHARISMA Investigators.Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.J Am Coll Cardiol.2007; 49(19): 1982-1988, doi: 10.1016/j.jacc.2007.03.025, indexed in Pubmed: 17498584.
Markus HS, Droste DW, Kaps M, et al.Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using doppler embolic signal detection: The Clopidogrel and Aspirin for Reduction of Emboli in Symptomatic Carotid Stenosis (CARESS) trial.Circulation.2005; 111(17): 2233-2240, doi: 10.1161/01.
Wang Y, Wang Y, Zhao X, et al.CHANCE Investigators.Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.N Engl J Med.2013; 369(1): 11-19, doi: 10.1056/NEJMoa1215340, indexed in Pubmed: 23803136.
Dalainas I, Nano G, Bianchi P, et al.Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting.Cardiovasc Intervent Radiol.2006; 29(4): 519-521, doi: 10.1007/s00270-005-5288-y, indexed in Pubmed: 16565792.
McKevitt FM, Randall MS, Cleveland TJ, et al.The benefits of combined anti-platelet treatment in carotid artery stenting.Eur J Vasc Endovasc Surg.2005; 29(5): 522-527, indexed in Pubmed: 15966092.
Gensicke H, van der Worp HB, Nederkoorn PJ, et al.ICSS-MRI Substudy Investigators.Ischemic brain lesions after carotid artery stenting increase future cerebrovascular risk.J Am Coll Cardiol.2015; 65(6): 521-529, doi: 10.1016/j.jacc.2014.11.038, indexed in Pubmed: 25677309.
Udell JA, Bonaca MP, Collet JP, et al.Long-term dual antiplatelet therapy for secondary prevention of cardiovascular events in the subgroup of patients with previous myocardial infarction: A collaborative meta-analysis of randomized trials.Eur Heart J.2016; 37(4): 390-399, doi: 10.1093/eurheartj/ehv443, indexed in Pubmed: 26324537.
Schmit K, Dolor RJ, Jones WS, et al.Comparative effectiveness review of antiplatelet agents in peripheral artery disease.J Am Heart Assoc.2014; 3(6): E001330, doi: 10.1161/JAHA.113.001330, indexed in Pubmed: 25477329.
Belch JJF, Dormandy J, Biasi GM, et al.Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial.J Vasc Surg.2010; 52(4): 825-33, 833.e1, doi: 10.1016/j.jvs.2010.04.027, indexed in Pubmed: 20678878.
Cacoub PP, Bhatt DL, Steg PG, et al.CHARISMA Investigators.Patients with peripheral arterial disease in the CHARISMA trial.Eur Heart J.2009; 30(2): 192-201, doi: 10.1093/eurheartj/ehn534, indexed in Pubmed: 19136484.
Fowkes FG, Price JF, Stewart MCW, et al.Aspirin for Asymptomatic Atherosclerosis Trialists.Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: A randomized controlled trial.JAMA.2010; 303(9): 841-848, doi: 10.1001/jama.2010.221, indexed in Pubmed: 20197530.
Belch J, MacCuish A, Campbell I, et al.The prevention of progression of arterial disease and diabetes (POPADAD) trial: Factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.BMJ.2008; 337: A1840, indexed in Pubmed: 18927173.
Berger JS, Krantz MJ, Kittelson JM, et al.Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: A meta-analysis of randomized trials.JAMA.2009; 301(18): 1909- 1919, doi: 10.1001/jama.2009.623, indexed in Pubmed: 19436018.
Hiatt WR, Fowkes FG, Heizer G, et al.EUCLID Trial Steering Committee and Investigators.Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.N Engl J Med.2017; 376(1): 32-40, doi: 10.1056/NEJMoa1611688, indexed in Pubmed: 27959717.
Bonaca MP, Scirica BM, Creager MA, et al.Vorapaxar in patients with peripheral artery disease: Results from TRA2{degrees}P-TIMI 50.Circulation.2013; 127(14): 1522-9, 1529e1, doi: 10.1161/CIRCULATIONAHA.112.000679, indexed in Pubmed: 23501976.
Bonaca MP, Gutierrez JA, Creager MA, et al.Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis- Thrombolysis in Myocardial Infarction 50 (TRA2P-TIMI 50).Circulation.2016; 133(10): 997-1005, doi: 10.1161/CIRCULATIONAHA.115.019355, indexed in Pubmed: 26826179.
Bedenis R, Lethaby A, Maxwell H, et al.Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery.Cochrane Database Syst Rev.2015(2): CD000535, doi: 10.1002/14651858.
Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral anticoagulants or Aspirin study): A randomised trial.Lancet.2000; 355(9201): 346-351, doi: 10.1016/s0140-6736(99)07199-8.
Johnson WC, Williford WO.Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: A prospective randomized study.J Vasc Surg.2002; 35(3): 413-421, indexed in Pubmed: 11877686.
Monaco M, Di Tommaso L, Pinna GB, et al.Combination therapy with warfarin plus clopidogrel improves outcomes in femoropopliteal bypass surgery patients.J Vasc Surg.2012; 56(1): 96-105, doi: 10.1016/j.jvs.2012.01.004, indexed in Pubmed: 22551909.
Dake MD, Ansel GM, Jaff MR, et al.Zilver PTX Investigators.Durable Clinical Effectiveness With Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial.Circulation.2016; 133(15): 1472-83; discussion 1483, doi: 10.1161/CIRCULATIONAHA.115.016900, indexed in Pubmed: 26969758.
Laird JR, Schneider PA, Tepe G, et al.Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA.J Am Coll Cardiol.2015; 66(21): 2329-2338, doi: 10.1016/j.jacc.2015.09.063, indexed in Pubmed: 26476467.
Dagher NN, Modrall JG.Pharmacotherapy before and after revascularization: Anticoagulation, antiplatelet agents, and statins.Semin Vasc Surg.2007; 20(1): 10-14, doi: 10.1053/j.semvascsurg.2007.02.006, indexed in Pubmed: 17386359.
Franzone A, Piccolo R, Gargiulo G, et al.Prolonged vs Short Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With or Without Peripheral Arterial Disease: A Subgroup Analysis of the PRODIGY Randomized Clinical Trial.JAMA Cardiol.2016; 1(7): 795-803, doi: 10.1001/jamacardio.2016.2811, indexed in Pubmed: 27572001.
Bonaca MP, Bhatt DL, Cohen M, et al.Long-term use of ticagrelor in patients with prior myocardial infarction.N Engl J Med.2015; 372(19): 1791-1800, doi: 10.1056/NEJMoa1500857, indexed in Pubmed: 25773268.
Bonaca MP, Bhatt DL, Storey RF, et al.Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.J Am Coll Cardiol.2016; 67(23): 2719-2728, doi: 10.1016/j.jacc.2016.03.524, indexed in Pubmed: 27046162.
Guidelines for DAPT (citation pending).
Kirchhof P, Benussi S, Kotecha D, et al.2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.Eur Heart J.2016; 37(38): 2893-2962, doi: 10.1093/eurheartj/ehw210, indexed in Pubmed: 27567408.
Winkel TA, Hoeks SE, Schouten O, et al.Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: Data from the REduction of Atherothrombosis for Continued Health (REACH) Registry.Eur J Vasc Endovasc Surg.2010; 40(1): 9-16, doi: 10.1016/j.ejvs.2010.03.003, indexed in Pubmed: 20385507.
Jones WS, Hellkamp AS, Halperin J, et al.Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: Insights from ROCKET AF.Eur Heart J.2014; 35(4): 242-249, doi: 10.1093/eurheartj/eht492, indexed in Pubmed: 24302273.
Heidbuchel H, Verhamme P, Alings M, et al.Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation.Europace.2015; 17(10): 1467-1507, doi: 10.1093/europace/euv309, indexed in Pubmed: 26324838.
Baigent C, Blackwell L, Collins R, et al.Antithrombotic Trialists' (ATT) Collaboration.Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials.Lancet.2009; 373(9678): 1849-1860, doi: 10.1016/S0140-6736(09)60503-1, indexed in Pubmed: 19482214.
Donaldson DR, Kester RC, Rajah SM, et al.The influence of platelet inhibition on the patency of femoro-popliteal Dacron bypass grafts.Vasc Endovasc Surg.1985; 19: 224-230.
McCollum C, Alexander C, Kenchington G, et al.Antiplatelet drugs in femoropopliteal vein bypasses: A multicenter trial.J Vasc Surg.1991; 13(1): 150-61; discussion 161, indexed in Pubmed: 1987387.
Hart RG, Pearce LA, Aguilar MI.Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.Ann Intern Med.2007; 146(12): 857-867, indexed in Pubmed: 17577005.
Lamberts M, Lip G, Ruwald M, et al.Antithrombotic Treatment in Patients With Heart Failure and Associated Atrial Fibrillation and Vascular Disease.J Am Coll Cardiol.2014; 63(24): 2689-2698, doi: 10.1016/j.jacc.2014.03.039.
Sacco RL, Kasner SE, Broderick JP, et al.American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, Council on Nutrition, Physical Activity and Metabolism.An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American Heart Association/American Stroke Association.Stroke.2013; 44(7): 2064-2089, doi: 10.1161/STR.0b013e318296aeca, indexed in Pubmed: 23652265.
Donnan GA, Davis SM, Chambers BR, et al.Surgery for prevention of stroke.Lancet.1998; 351(9113): 1372-1373, indexed in Pubmed: 9593402.
Sprynger M, Moonen M, Aboyans V, et al.EACVI recommendations on echovascular imaging assessment of arterial diseases: Partim I.In preparation.2017.
Esposito-Bauer L, Saam T, Ghodrati I, et al.MRI plaque imaging detects carotid plaques with a high risk for future cerebrovascular events in asymptomatic patients.PLoS One.2013; 8(7): E67927, doi: 10.1371/journal.pone.0067927, indexed in Pubmed: 23894291.
Gupta A, Kesavabhotla K, Baradaran H, et al.Plaque echolucency and stroke risk in asymptomatic carotid stenosis: A systematic review and meta-analysis.Stroke.2015; 46(1): 91-97, doi: 10.1161/STROKEAHA.114.006091, indexed in Pubmed: 25406150.
Naylor AR, Schroeder TV, Sillesen H.Clinical and imaging features associated with an increased risk of late stroke in patients with asymptomatic carotid disease.Eur J Vasc Endovasc Surg.2014; 48(6): 633-640, doi: 10.1016/j.ejvs.2014.08.017, indexed in Pubmed: 25266404.
Sloan MA, Alexandrov AV, Tegeler CH, et al.Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.Assessment: Transcranial Doppler ultrasonography: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.Neurology.2004; 62(9): 1468-1481, indexed in Pubmed: 15136667.
Wardlaw J, Chappell F, Stevenson M, et al.Accurate, practical and cost-effective assessment of carotid stenosis in the UK.Health Technol Assess.2006; 10(30), doi: 10.3310/hta10300.
Blackshear JL, Cutlip DE, Roubin GS, et al.CREST Investigators.Myocardial infarction after carotid stenting and endarterectomy: Results from the carotid revascularization endarterectomy versus stenting trial.Circulation.2011; 123(22): 2571-2578, doi: 10.1161/CIRCULATIONAHA.110.008250, indexed in Pubmed: 21606394.
Giannakopoulos TG, Moulakakis K, Sfyroeras GS, et al.Association between plaque echogenicity and embolic material captured in filter during protected carotid angioplasty and stenting.Eur J Vasc Endovasc Surg.2012; 43(6): 627-631, doi: 10.1016/j.ejvs.2012.03.004, indexed in Pubmed: 22487782.
Akkaya E, Vuruskan E, Gul ZB, et al.Cerebral microemboli and neurocognitive change after carotid artery stenting with different embolic protection devices.Int J Cardiol.2014; 176(2): 478-483, doi: 10.1016/j.ijcard.2014.07.241, indexed in Pubmed: 25125014.
Bijuklic K, Wandler A, Hazizi F, et al.The PROFI study (Prevention of Cerebral Embolization by Proximal Balloon Occlusion Compared to Filter Protection During Carotid Artery Stenting): A prospective randomized trial.J Am Coll Cardiol.2012; 59(15): 1383-1389, doi: 10.1016/j.jacc.2011.11.035, indexed in Pubmed: 22284330.
Cano MN, Kambara AM, de Cano SJF, et al.Randomized comparison of distal and proximal cerebral protection during carotid artery stenting.JACC Cardiovasc Interv.2013; 6(11): 1203-1209, doi: 10.1016/j.jcin.2013.07.006, indexed in Pubmed: 24262620.
Montorsi P, Caputi L, Galli S, et al.Microembolization during carotid artery stenting in patients with high-risk, lipid-rich plaque.A randomized trial of proximal versus distal cerebral protection.J Am Coll Cardiol.2011; 58(16): 1656-1663, doi: 10.1016/j.jacc.2011.07.015, indexed in Pubmed: 21982309.
Stabile E, Esposito G.Operator's Experience Is the Most Efficient Embolic Protection Device for Carotid Artery Stenting.Circ Cardiovasc Interv.2013; 6(5): 496-497, doi: 10.1161/circinterventions.113.000814.
Garg N, Karagiorgos N, Pisimisis GT, et al.Cerebral protection devices reduce periprocedural strokes during carotid angioplasty and stenting: A systematic review of the current literature.J Endovasc Ther.2009; 16(4): 412-427, doi: 10.1583/09-2713.1, indexed in Pubmed: 19702342.
Touze E, Trinquart L, Chatellier G, et al.Systematic review of the periopera- tive risks of stroke or death after carotid angioplasty and stenting.Stroke.2009; 40: E683-e693.
Zahn R, Ischinger T, Hochadel M, et al.Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte.Carotid artery stenting in octogenarians: Results from the ALKK Carotid Artery Stent (CAS) Registry.Eur Heart J.2007; 28(3): 370-375, doi: 10.1093/eurheartj/ehl421, indexed in Pubmed: 17158826.
Rosenfield K, Matsumura JS, Chaturvedi S, et al.ACT I Investigators.Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis.N Engl J Med.2016; 374(11): 1011-1020, doi: 10.1056/NEJMoa1515706, indexed in Pubmed: 26886419.
Jansen O, Fiehler J, Hartmann M, et al.Protection or nonprotection in carotid stent angioplasty: The influence of interventional techniques on outcome data from the SPACE Trial.Stroke.2009; 40(3): 841-846, doi: 10.1161/STROKEAHA.108.534289, indexed in Pubmed: 19150863.
Gray WA, Rosenfield KA, Jaff MR, et al.CAPTURE 2 Investigators and Executive Committee.Influence of site and operator characteristics on carotid artery stent outcomes: Analysis of the CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events) clinical study.JACC Cardiovasc Interv.2011; 4(2): 235-246, doi: 10.1016/j.jcin.2010.10.009, indexed in Pubmed: 21349464.
Nallamothu BK, Gurm HS, Ting HH, et al.Operator experience and carotid stenting outcomes in Medicare beneficiaries.JAMA.2011; 306(12): 1338-1343, doi: 10.1001/jama.2011.1357, indexed in Pubmed: 21954477.
Endarterectomy for asymptomatic carotid artery stenosis.Executive Committee for the Asymptomatic Carotid Atherosclerosis Study.JAMA.1995; 273(18): 1421-1428, indexed in Pubmed: 7723155.
Halliday A, Harrison M, Hayter E, et al.Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group.10-year stroke prevention after successful carotid endarterectomy for asymptomatic stenosis (ACST-1): A multicentre randomised trial.Lancet.2010; 376(9746): 1074-1084, doi: 10.1016/S0140-6736(10)61197-X, indexed in Pubmed: 20870099.
Halliday A, Mansfield A, Marro J, et al.MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group.Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: Randomised controlled trial.Lancet.2004; 363(9420): 1491-1502, doi: 10.1016/S0140- 6736(04)16146-1, indexed in Pubmed: 15135594.
Rothwell PM, Eliasziw M, Gutnikov SA, et al.Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke.Stroke.2004; 35(12): 2855-2861, doi: 10.1161/01.STR.0000147040.20446.f6, indexed in Pubmed: 15514193.
Hadar N, Raman G, Moorthy D, et al.Asymptomatic carotid artery stenosis treated with medical therapy alone: Temporal trends and implications for risk assessment and the design of future studies.Cerebrovasc Dis.2014; 38(3): 163-173, doi: 10.1159/000365206, indexed in Pubmed: 25300534.
Naylor AR, Gaines PA, Rothwell PM.Who benefits most from intervention for asymptomatic carotid stenosis: Patients or professionals? Eur J Vasc Endovasc Surg.2009; 37(6): 625-632, doi: 10.1016/j.ejvs.2009.01.026, indexed in Pubmed: 19345591.
Baker WH, Howard VJ, Howard G, et al.Effect of contralateral occlusion on long-term efficacy of endarterectomy in the asymptomatic carotid atherosclerosis study (ACAS).ACAS Investigators.Stroke.2000; 31(10): 2330-2334, indexed in Pubmed: 11022059.
Nicolaides AN, Kakkos SK, Griffin M, et al.Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group.Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: Results from the ACSRS study.Eur J Vasc Endovasc Surg.2005; 30(3): 275-284, indexed in Pubmed: 16130207.
Kakkos SK, Sabetai M, Tegos T, et al.Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis.J Vasc Surg.2009; 49(4): 902-909, doi: 10.1016/j.jvs.2008.10.059, indexed in Pubmed: 19223148.
Kakkos SK, Nicolaides AN, Charalambous I, et al.Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group.Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis.J Vasc Surg.2014; 59(4): 956-967.e1, doi: 10.1016/j.jvs.2013.10.073, indexed in Pubmed: 24377944.
Markus HS, King A, Shipley M, et al.Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): A prospective observational study.Lancet Neurol.2010; 9(7): 663-671, doi: 10.1016/S1474-4422(10)70120-4, indexed in Pubmed: 20554250.
King A, Serena J, Bornstein NM, et al.Does impaired cerebrovascular reactivity predict stroke risk in asymptomatic carotid stenosis? A prospective substudy of the asymptomatic carotid emboli study.Stroke.2011; 42(6): 1550-1555, doi: 10.1161/STROKEAHA.110.609057, indexed in Pubmed: 21527764.
Kyriacou E, Nicolaides A, Pattichis CS, et al.Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification.J Vasc Surg.2010; 52(6): 1486-1496.e1, doi: 10.1016/j.jvs.2010.07.021, indexed in Pubmed: 21146746.
Kakkos SK, Griffin MB, Nicolaides AN, et al.Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group.The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke.J Vasc Surg.2013; 57(3): 609-618.e1; discussion 617, doi: 10.1016/j.jvs.2012.09.045, indexed in Pubmed: 23337294.
Gupta A, Baradaran H, Schweitzer AD, et al.Carotid plaque MRI and stroke risk: A systematic review and meta-analysis.Stroke.2013; 44(11): 3071-3077, doi: 10.1161/STROKEAHA.113.002551, indexed in Pubmed: 23988640.
Hawkins BM, Kennedy KF, Aronow HD, et al.Hospital variation in carotid stenting outcomes.JACC Cardiovasc Interv.2015; 8(6): 858-863, doi: 10.1016/j.jcin.2015.01.026, indexed in Pubmed: 25999111.
Kallmayer MA, Tsantilas P, Knappich C, et al.Patient characteristics and outcomes of carotid endarterectomy and carotid artery stenting: Analysis of the German mandatory national quality assurance registry - 2003 to 2014.J Cardiovasc Surg (Torino.2015; 56: 827-836.
Werner N, Zeymer U, Hochadel M, et al.Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte, Rheinland-Pfalz, Germany.Fifteen-year experience with carotid artery stenting (from the carotid artery stenting-registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte).Am J Cardiol.2015; 115(3): 360-366, doi: 10.1016/j.amjcard.2014.11.009, indexed in Pubmed: 25498539.
Paraskevas KI, Kalmykov EL, Naylor AR.Stroke/Death Rates Following Carotid Artery Stenting and Carotid Endarterectomy in Contemporary Administrative Dataset Registries: A Systematic Review.Eur J Vasc Endovasc Surg.2016; 51(1): 3-12, doi: 10.1016/j.ejvs.2015.07.032, indexed in Pubmed: 26346006.
Choi JC, Johnston SC, Kim AS.Early outcomes after carotid artery stenting compared with endarterectomy for asymptomatic carotid stenosis.Stroke.2015; 46(1): 120-125, doi: 10.1161/STROKEAHA.114.006209, indexed in Pubmed: 25424479.
Dua A, Romanelli M, Upchurch GR, et al.Predictors of poor outcome after carotid intervention.J Vasc Surg.2016; 64(3): 663-670, doi: 10.1016/j.jvs.2016.03.428, indexed in Pubmed: 27209401.
Yadav JS, Wholey MH, Kuntz RE, et al.Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators.Protected carotid-artery stenting versus endarterectomy in high-risk patients.N Engl J Med.2004; 351(15): 1493-1501, doi: 10.1056/NEJMoa040127, indexed in Pubmed: 15470212.
Gurm HS, Yadav JS, Fayad P, et al.Long-term results of carotid stenting versus endarterectomy in high-risk patients.N Engl J Med.2008; 358(15): 1572-1579, doi: 10.1056/NEJMoa0708028, indexed in Pubmed: 18403765.
Silver FL, Mackey A, Clark WM, et al.Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).Stroke.2011; 42(3): 675-680, doi: 10.1161/STROKEAHA.110.610212, indexed in Pubmed: 21307169.
Rothwell PM, Eliasziw M, Gutnikov SA, et al.Carotid Endarterectomy Trialists' Collaboration.Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis.Lancet.2003; 361(9352): 107-116, indexed in Pubmed: 12531577.
Naylor AR, Sillesen H, Schroeder TV.Clinical and imaging features associated with an increased risk of early and late stroke in patients with symptomatic carotid disease.Eur J Vasc Endovasc Surg.2015; 49(5): 513-523, doi: 10.1016/j.ejvs.2015.01.011, indexed in Pubmed: 25747345.
Strömberg S, Gelin J, Osterberg T, et al.Swedish Vascular Registry (Swedvasc) Steering Committee.Very urgent carotid endarterectomy confers increased procedural risk.Stroke.2012; 43(5): 1331-1335, doi: 10.1161/STROKEAHA.111.639344, indexed in Pubmed: 22426315.
Loftus IM, Paraskevas KI, Johal A, et al.Delays to Surgery and Procedural Risks Following Carotid Endarterectomy in the UK National Vascular Registry.Eur J Vasc Endovasc Surg.2016; 52(4): 438-443, doi: 10.1016/j.ejvs.2016.05.031.
Tsantilas P, Kuehnl A, König T, et al.Short Time Interval Between Neurologic Event and Carotid Surgery Is Not Associated With an Increased Procedural Risk.Stroke.2016; 47(11): 2783-2790, doi: 10.1161/STROKEAHA.116.014058, indexed in Pubmed: 27738236.
Bush CK, Kurimella D, Cross LJS, et al.Endovascular Treatment with Stent-Retriever Devices for Acute Ischemic Stroke: A Meta- -Analysis of Randomized Controlled Trials.PLoS One.2016; 11(1): E0147287, doi: 10.1371/journal.pone.0147287, indexed in Pubmed: 26807742.
Berkhemer OA, Fransen PSS, Beumer D, et al.A randomized trial of intraarterial treatment for acute ischemic stroke.N Engl J Med.2015; 372(1): 11-20, doi: 10.1056/NEJMoa1411587, indexed in Pubmed: 25517348.
Brott TG, Hobson RW, Howard G, et al.Stenting versus endarterectomy for treatment of carotid-artery stenosis.N Engl J Med.2010; 363(1): 11-23, doi: 10.1056/NEJMoa0912321, indexed in Pubmed: 20505173.
Brott TG, Howard G, Roubin GS, et al.Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST).Circulation.2012; 126(25): 3054-3061, doi: 10.1161/CIRCULATIONAHA.112.120030, indexed in Pubmed: 23159552.
Economopoulos KP, Sergentanis TN, Tsivgoulis G, et al.Carotid artery stenting versus carotid endarterectomy: A comprehensive meta-analysis of short-term and long-term outcomes.Stroke.2011; 42(3): 687-692, doi: 10.1161/STROKEAHA.110.606079, indexed in Pubmed: 21233476.
Bonati LH, Lyrer P, Ederle J, et al.Percutaneous transluminal balloon angioplasty and stenting for carotid artery stenosis.Cochrane Database Syst Rev.2012(9): CD000515, doi: 10.1002/14651858.CD000515.pub4, indexed in Pubmed: 22972047.
Rantner B, Goebel G, Bonati LH, et al.Carotid Stenting Trialists' Collaboration.The risk of carotid artery stenting compared with carotid endarterectomy is greatest in patients treated within 7 days of symptoms.J Vasc Surg.2013; 57(3): 619-626.e2; discussion 625, doi: 10.1016/j.jvs.2012.08.107, indexed in Pubmed: 23237679.
Meschia JF, Hopkins LN, Altafullah I, et al.Time From Symptoms to Carotid Endarterectomy or Stenting and Perioperative Risk.Stroke.2015; 46(12): 3540-3542, doi: 10.1161/STROKEAHA.115.011123, indexed in Pubmed: 26493675.
Howard G, Roubin G, Jansen O, et al.Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: A meta-analysis of pooled patient data from four randomised trials.Lancet.2016; 387(10025): 1305-1311, doi: 10.1016/s0140-6736(15)01309-4.
Bonati LH, Dobson J, Featherstone RL, et al.Long-term outcomes after stenting versus endarterectomy for treatment of symptomatic carotid stenosis: The International Carotid Stenting Study (ICSS) randomised trial.Lancet.2015; 385(9967): 529-538, doi: 10.1016/S0140-6736(14)61184-3, indexed in Pubmed: 25453443.
Brott TG, Howard G, Roubin GS, et al.CREST Investigators.Long- -Term Results of Stenting versus Endarterectomy for Carotid- -Artery Stenosis.N Engl J Med.2016; 374(11): 1021-1031, doi: 10.1056/NEJMoa1505215, indexed in Pubmed: 26890472.
Randomised trial of endarterectomy for recently symptomatic carotid stenosis: Final results of the MRC European Carotid Surgery Trial (ECST).Lancet.1998; 351(9113): 1379-1387, indexed in Pubmed: 9593407.
Barnett HJ, Taylor DW, Eliasziw M, et al.Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis.North American Symptomatic Carotid Endarterectomy Trial Collaborators.N Engl J Med.1998; 339(20): 1415-1425, doi: 10.1056/NEJM199811123392002, indexed in Pubmed: 9811916.
Borhani Haghighi A, Edgell RC, Cruz-Flores S, et al.Vertebral artery origin stenosis and its treatment.J Stroke Cerebrovasc Dis.2011; 20(4): 369-376, doi: 10.1016/j.jstrokecerebrovasdis.2011.05.007, indexed in Pubmed: 21729790.
Khan S, Cloud GC, Kerry S, et al.Imaging of vertebral artery stenosis: A systematic review.J Neurol Neurosurg Psychiatry.2007; 78(11): 1218-1225, doi: 10.1136/jnnp.2006.111716, indexed in Pubmed: 17287234.
Kumar Dundamadappa S, Cauley K.Vertebral artery ostial stenosis: Prevalence by digital subtraction angiography, MR angiography, and CT angiography.J Neuroimaging.2013; 23(3): 360-367, doi: 10.1111/j.1552-6569.2011.00692.x, indexed in Pubmed: 22251073.
Berguer R, Flynn LM, Kline RA, et al.Surgical reconstruction of the extracranial vertebral artery: Management and outcome.J Vasc Surg.2000; 31(1 Pt 1): 9-18, indexed in Pubmed: 10642704.
Kieffer E, Praquin B, Chiche L, et al.Distal vertebral artery reconstruction: Long-term outcome.J Vasc Surg.2002; 36(3): 549-554, indexed in Pubmed: 12218980.
Stayman AN, Nogueira RG, Gupta R.A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis.Stroke.2011; 42(8): 2212-2216, doi: 10.1161/STROKEAHA.110.611459, indexed in Pubmed: 21700936.
Compter A, van der Worp HB, Schonewille WJ, et al.VAST investigators.Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: A randomised open-label phase 2 trial.Lancet Neurol.2015; 14(6): 606-614, doi: 10.1016/S1474- 4422(15)00017-4, indexed in Pubmed: 25908089.
Aboyans V, Criqui MH, McDermott MM, et al.The vital prognosis of subclavian stenosis.J Am Coll Cardiol.2007; 49(14): 1540-1545, doi: 10.1016/j.jacc.2006.09.055, indexed in Pubmed: 17418292.
Klitfod L, Jensen LP.Treatment of chronic upper limb ischaemia is safe and results are good.Dan Med J.2014; 61(6): A4859, indexed in Pubmed: 24947629.
Daniel VT, Madenci AL, Nguyen LL, et al.Contemporary comparison of supra-aortic trunk surgical reconstructions for occlusive disease.J Vasc Surg.2014; 59(6): 1577-82, 1582.e1, doi: 10.1016/j.jvs.2013.12.017, indexed in Pubmed: 24447542.
Duran M, Grotemeyer D, Danch MA, et al.Subclavian carotid transposition: Immediate and long-term outcomes of 126 surgical reconstructions.Ann Vasc Surg.2015; 29(3): 397-403, doi: 10.1016/j.avsg.2014.09.030, indexed in Pubmed: 25463327.
Burihan E, Soma F, Iared W.Angioplasty versus stenting for subclavian artery stenosis.Cochrane Database Syst Rev.2011(10): CD008461, doi: 10.1002/14651858.CD008461.pub2, indexed in Pubmed: 21975782.
Chatterjee S, Nerella N, Chakravarty S, et al.Angioplasty alone versus angioplasty and stenting for subclavian artery stenosis- -A systematic review and meta-analysis.Am J Ther.2013; 20(5): 520-523, doi: 10.1097/MJT.0b013e31822831d8, indexed in Pubmed: 23344091.
Hüttl K, Nemes B, Simonffy A, et al.Angioplasty of the innominate artery in 89 patients: Experience over 19 years.Cardiovasc Intervent Radiol.2002; 25(2): 109-114, doi: 10.1007/s00270-001-0074-y, indexed in Pubmed: 11901427.
Van de Weijer MA, Vonken EJ, de Vries JPPM, et al.Technical and Clinical Success and Long-Term Durability of Endovascular Treatment for Atherosclerotic Aortic Arch Branch Origin Obstruction: Evaluation of 144 Procedures.Eur J Vasc Endovasc Surg.2015; 50(1): 13-20, doi: 10.1016/j.ejvs.2015.03.058, indexed in Pubmed: 26021529.
Modarai B, Ali T, Dourado R, et al.Comparison of extra-anatomic bypass grafting with angioplasty for atherosclerotic disease of the supra-aortic trunks.Br J Surg.2004; 91(11): 1453-1457, doi: 10.1002/bjs.4751, indexed in Pubmed: 15386319.
Owens LV, Tinsley EA, Criado E, et al.Extrathoracic reconstruction of arterial occlusive disease involving the supraaortic trunks.J Vasc Surg.1995; 22(3): 217-21; discussion 221, indexed in Pubmed: 7674463.
Song L, Zhang J, Li J, et al.Endovascular stenting vs.extrathoracic surgical bypass for symptomatic subclavian steal syndrome.J Endovasc Ther.2012; 19(1): 44-51, doi: 10.1583/11-3692.1, indexed in Pubmed: 22313201.
Lee AD, Agarwal S, Sadhu D.A 7-year experience with thoracoscopic sympathectomy for critical upper limb ischemia.World J Surg.2006; 30(9): 1644-1647, doi: 10.1007/s00268-005-0559-y, indexed in Pubmed: 16902742.
Björck M, Koelemay M, Acosta S, et al.Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS).Eur J Vasc Endovasc Surg.2017; 53(4): 460-510, doi: 10.1016/j.ejvs.2017.01.010, indexed in Pubmed: 28359440.
Acosta S, Nilsson TK, Björck M.D-dimer testing in patients with suspected acute thromboembolic occlusion of the superior mesenteric artery.Br J Surg.2004; 91(8): 991-994, doi: 10.1002/bjs.4645, indexed in Pubmed: 15286959.
Block T, Nilsson TK, Björck M, et al.Diagnostic accuracy of plasma biomarkers for intestinal ischaemia.Scand J Clin Lab Invest.2008; 68(3): 242-248, doi: 10.1080/00365510701646264, indexed in Pubmed: 17934974.
Matsumoto S, Sekine K, Funaoka H, et al.Diagnostic performance of plasma biomarkers in patients with acute intestinal ischaemia.Br J Surg.2014; 101(3): 232-238, doi: 10.1002/bjs.9331, indexed in Pubmed: 24402763.
Cudnik MT, Darbha S, Jones J, et al.The diagnosis of acute mesenteric ischemia: A systematic review and meta-analysis.Acad Emerg Med.2013; 20(11): 1087-1100, doi: 10.1111/acem.12254, indexed in Pubmed: 24238311.
Lehtimäki TT, Kärkkäinen JM, Saari P, et al.Detecting acute mesenteric ischemia in CT of the acute abdomen is dependent on clinical suspicion: Review of 95 consecutive patients.Eur J Radiol.2015; 84(12): 2444-2453, doi: 10.1016/j.ejrad.2015.09.006, indexed in Pubmed: 26413771.
Jrvinen O, Laurikka J, Salenius JP, et al.Acute intestinal ischaemia.A review of 214 cases.Ann Chir Gynaecol.1994; 83(1): 22-25, indexed in Pubmed: 8053632.
Beaulieu RJ, Arnaoutakis KD, Abularrage CJ, et al.Comparison of open and endovascular treatment of acute mesenteric ischemia.J Vasc Surg.2014; 59(1): 159-164, doi: 10.1016/j.jvs.2013.06.084, indexed in Pubmed: 24199769.
Björck M, Orr N, Endean ED.Debate: Whether an endovascular- -first strategy is the optimal approach for treating acute mesenteric ischemia.J Vasc Surg.2015; 62(3): 767-772, doi: 10.1016/j.jvs.2015.04.431, indexed in Pubmed: 26304485.
Block TA, Acosta S, Björck M.Endovascular and open surgery for acute occlusion of the superior mesenteric artery.J Vasc Surg.2010; 52(4): 959-966, doi: 10.1016/j.jvs.2010.05.084, indexed in Pubmed: 20620006.
Kalra M, Ryer EJ, Oderich GS, et al.Contemporary results of treatment of acute arterial mesenteric thrombosis: Has endovascular treatment improved outcomes? Perspect Vasc Surg Endovasc Ther.2012; 24(4): 171-176, doi: 10.1177/1531003513490033, indexed in Pubmed: 23698701.
Wyers MC, Powell RJ, Nolan BW, et al.Retrograde mesenteric stenting during laparotomy for acute occlusive mesenteric ischemia.J Vasc Surg.2007; 45(2): 269-275, doi: 10.1016/j.jvs.2006.10.047, indexed in Pubmed: 17264001.
Arthurs ZM, Titus J, Bannazadeh M, et al.A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia.J Vasc Surg.2011; 53(3): 698-704, doi: 10.1016/j.jvs.2010.09.049, indexed in Pubmed: 21236616.
Schermerhorn ML, Giles KA, Hamdan AD, et al.Mesenteric revascularization: Management and outcomes in the United States, 1988-2006.J Vasc Surg.2009; 50(2): 341-348.e1, doi: 10.1016/j.jvs.2009.03.004, indexed in Pubmed: 19372025.
Rotondo M, Schwab C, McGonigal M, et al.Damage Control: An approach for improved survival in exsanguinating penetrating abdominal injury.J Trauma.1993; 35(3): 375-383, doi: 10.1097/00005373-199309000-00008.
Björck M, Acosta S, Lindberg F, et al.Revascularization of the superior mesenteric artery after acute thromboembolic occlusion.Br J Surg.2002; 89(7): 923-927, doi: 10.1046/j.1365- -2168.2002.02150.x, indexed in Pubmed: 12081744.
Björnsson S, Björck M, Block T, et al.Thrombolysis for acute occlusion of the superior mesenteric artery.J Vasc Surg.2011; 54(6): 1734-1742, doi: 10.1016/j.jvs.2011.07.054, indexed in Pubmed: 21889287.
Thomas JH, Blake K, Pierce GE, et al.The clinical course of asymptomatic mesenteric arterial stenosis.J Vasc Surg.1998; 27(5): 840-844, indexed in Pubmed: 9620135.
Van Petersen AS, Meerwaldt R, Kolkman JJ, et al.The influence of respiration on criteria for transabdominal duplex examination of the splanchnic arteries in patients with suspected chronic splanchnic ischemia.J Vasc Surg.2013; 57(6): 1603-11, 1611.e1, doi: 10.1016/j.jvs.2012.11.120, indexed in Pubmed: 23719037.
Zwolak RM, Fillinger MF, Walsh DB, et al.Mesenteric and celiac duplex scanning: A validation study.J Vasc Surg.1998; 27(6): 1078-87; discussion 1088, indexed in Pubmed: 9652470.
Rheudasil JM, Stewart MT, Schellack JV, et al.Surgical treatment of chronic mesenteric arterial insufficiency.J Vasc Surg.1988; 8(4): 495-500, indexed in Pubmed: 3172386.
Moghadamyeghaneh Z, Carmichael JC, Mills SD, et al.Early Outcome of Treatment of Chronic Mesenteric Ischemia.Am Surg.2015; 81(11): 1149-1156, indexed in Pubmed: 26672586.
Rawat N, Gibbons C.Surgical or Endovascular Treatment for Chronic Mesenteric Ischemia: A Multicenter Study.An Vasc Surg.2010; 24(7): 935-945, doi: 10.1016/j.avsg.2010.05.007.
Peck MA, Conrad MF, Kwolek CJ, et al.Intermediate-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia.J Vasc Surg.2010; 51(1): 140-147.e1, doi: 10.1016/j.jvs.2009.06.064, indexed in Pubmed: 19837530.
Silva JA, White CJ, Collins TJ, et al.Endovascular therapy for chronic mesenteric ischemia.J Am Coll Cardiol.2006; 47(5): 944-950, doi: 10.1016/j.jacc.2005.10.056, indexed in Pubmed: 16516076.
Malgor RD, Oderich GS, McKusick MA, et al.Results of singleand two-vessel mesenteric artery stents for chronic mesenteric ischemia.Ann Vasc Surg.2010; 24(8): 1094-1101, doi: 10.1016/j.avsg.2010.07.001, indexed in Pubmed: 21035701.
Oderich GS, Erdoes LS, Lesar C, et al.Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease.J Vasc Surg.2013; 58(5): 1316-1323, doi: 10.1016/j.jvs.2013.05.013, indexed in Pubmed: 23827340.
Menke J, Lüthje L, Kastrup A, et al.Thromboembolism in atrial fibrillation.Am J Cardiol.2010; 105(4): 502-510, doi: 10.1016/j.amjcard.2009.10.018, indexed in Pubmed: 20152245.
Mensink PBF, van Petersen AS, Geelkerken RH, et al.Clinical significance of splanchnic artery stenosis.Br J Surg.2006; 93(11): 1377-1382, doi: 10.1002/bjs.5481, indexed in Pubmed: 17022013.
Hirsch AT, Haskal ZJ, Hertzer NR, et al.2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.Circulation.2006; 113: E463-e654.
Persu A, Giavarini A, Touzé E, et al.ESH Working Group Hypertension and the Kidney.European consensus on the diagnosis and management of fibromuscular dysplasia.J Hypertens.2014; 32(7): 1367-1378, doi: 10.1097/HJH.0000000000000213, indexed in Pubmed: 24842696.
Tafur-Soto JD, White CJ.Renal artery stenosis.Cardiol Clin.2015; 33(1): 59-73, doi: 10.1016/j.ccl.2014.09.006, indexed in Pubmed: 25439331.
Messerli FH, Bangalore S, Makani H, et al.Flash pulmonary oedema and bilateral renal artery stenosis: The Pickering syndrome.Eur Heart J.2011; 32(18): 2231-2235, doi: 10.1093/eurheartj/ehr056, indexed in Pubmed: 21406441.
Jennings CG, Houston JG, Severn A, et al.Renal artery stenosis- -when to screen, what to stent? Curr Atheroscler Rep.2014; 16(6): 416, doi: 10.1007/s11883-014-0416-2, indexed in Pubmed: 24743868.
Zeller T, Bonvini RF, Sixt S.Color-coded duplex ultrasound for diagnosis of renal artery stenosis and as follow-up examination after revascularization.Catheter Cardiovasc Interv.2008; 71(7): 995-999, doi: 10.1002/ccd.21525, indexed in Pubmed: 18383154.
Williams GJ, Macaskill P, Chan SF, et al.Comparative accuracy of renal duplex sonographic parameters in the diagnosis of renal artery stenosis: Paired and unpaired analysis.AJR Am J Roentgenol.2007; 188(3): 798-811, doi: 10.2214/AJR.06.0355, indexed in Pubmed: 17312071.
AbuRahma AF, Yacoub M.Renal imaging: Duplex ultrasound, computed tomography angiography, magnetic resonance angiography, and angiography.Semin Vasc Surg.2013; 26(4): 134-143, doi: 10.1053/j.semvascsurg.2014.06.001, indexed in Pubmed: 25220318.
Tan KT, van Beek EJR, Brown PWG, et al.Magnetic resonance angiography for the diagnosis of renal artery stenosis: A meta- -analysis.Clin Radiol.2002; 57(7): 617-624, indexed in Pubmed: 12096862.
Drieghe B, Madaric J, Sarno G, et al.Assessment of renal artery stenosis severity by pressure gradient measurements.J Am Coll Cardiol.2006; 48(9): 1851-1855, doi: 10.1016/j.jacc.2006.05.074, indexed in Pubmed: 17084261.
Drieghe B, Madaric J, Sarno G, et al.Assessment of renal artery stenosis: Side-by-side comparison of angiography and duplex ultrasound with pressure gradient measurements.Eur Heart J.2008; 29(4): 517-524, doi: 10.1093/eurheartj/ehm631, indexed in Pubmed: 18276621.
Conlon PJ, Little MA, Pieper K, et al.Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography.Kidney Int.2001; 60(4): 1490-1497, doi: 10.1046/j.1523- -1755.2001.00953.x, indexed in Pubmed: 11576364.
Mailloux LU, Napolitano B, Bellucci AG, et al.Renal vascular disease causing end-stage renal disease, incidence, clinical correlates, and outcomes: A 20-year clinical experience.Am J Kidney Dis.1994; 24(4): 622-629, indexed in Pubmed: 7942820.
Catapano AL, Graham I, De Backer G, et al.2016 ESC/EAS Guidelines for the Management of Dyslipidaemias.Eur Heart J.2016; 37(39): 2999-3058, doi: 10.1093/eurheartj/ehw272, indexed in Pubmed: 27567407.
Evans KL, Tuttle KR, Folt DA, et al.Use of renin-angiotensin inhibitors in people with renal artery stenosis.Clin J Am Soc Nephrol.2014; 9(7): 1199-1206, doi: 10.2215/CJN.11611113, indexed in Pubmed: 24903387.
Hackam DG, Duong-Hua ML, Mamdani M, et al.Angiotensin inhibition in renovascular disease: A population-based cohort study.Am Heart J.2008; 156(3): 549-555, doi: 10.1016/j.ahj.2008.05.013, indexed in Pubmed: 18760140.
Chrysochou C, Foley RN, Young JF, et al.Dispelling the myth: The use of renin-angiotensin blockade in atheromatous renovascular disease.Nephrol Dial Transplant.2012; 27(4): 1403-1409, doi: 10.1093/ndt/gfr496, indexed in Pubmed: 21993376.
Losito A, Errico R, Santirosi P, et al.Long-term follow-up of atherosclerotic renovascular disease.Beneficial effect of ACE inhibition.Nephrol Dial Transplant.2005; 20(8): 1604-1609, doi: 10.1093/ndt/gfh865, indexed in Pubmed: 15870215.
Hackam DG, Wu F, Li P, et al.Statins and renovascular disease in the elderly: A population-based cohort study.Eur Heart J.2011; 32(5): 598-610, doi: 10.1093/eurheartj/ehq452, indexed in Pubmed: 21156722.
Vashist A, Heller EN, Brown EJ, et al.Renal artery stenosis: A cardiovascular perspective.Am Heart J.2002; 143(4): 559-564, indexed in Pubmed: 11923791.
Chrysant GS, Bates MC, Sullivan TM, et al.Proper patient selection yields significant and sustained reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: Long-term results from the HERCULES trial.J Clin Hypertens (Greenwich).2014; 16(7): 497-503, doi: 10.1111/jch.12341, indexed in Pubmed: 24909590.
Chrysant GS, Bates MC, Sullivan TM, et al.HERCULES Investigators, HERCULES Investigators.Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension: Results from the HERCULES trial.Catheter Cardiovasc Interv.2012; 80(3): 343-350, doi: 10.1002/ccd.24449, indexed in Pubmed: 22511402.
Nordmann AJ, Woo K, Parkes R, et al.Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials.Am J Med.2003; 114(1): 44-50, indexed in Pubmed: 12557864.
Bavry AA, Kapadia SR, Bhatt DL, et al.Renal artery revascularization: Updated meta-analysis with the CORAL trial.JAMA Intern Med.2014; 174(11): 1849-1851, doi: 10.1001/jamainternmed.2014.4332, indexed in Pubmed: 25222825.
Cooper CJ, Murphy TP, Cutlip DE, et al.Stenting and medical therapy for atherosclerotic renal-artery stenosis.N Engl J Med.2014; 370(1): 13-22, doi: 10.1056/NEJMoa1310753, indexed in Pubmed: 24245566.
Murphy TP, Cooper CJ, Matsumoto AH, et al.Renal Artery Stent Outcomes: Effect of Baseline Blood Pressure, Stenosis Severity, and Translesion Pressure Gradient.J Am Coll Cardiol.2015; 66(22): 2487-2494, doi: 10.1016/j.jacc.2015.09.073, indexed in Pubmed: 26653621.
Wheatley K, Ives N, Gray R, et al.ASTRAL Investigators.Revascularization versus medical therapy for renal-artery stenosis.N Engl J Med.2009; 361(20): 1953-1962, doi: 10.1056/NEJMoa0905368, indexed in Pubmed: 19907042.
Bax L, Woittiez AJJ, Kouwenberg HJ, et al.Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: A randomized trial.Ann Intern Med.2009; 150(12): 840-8, W150, indexed in Pubmed: 19414832.
Olin JW, Gornik HL, Bacharach JM, et al.Fibromuscular dysplasia: State of the science and critical unanswered questions: A scientific statement from the American Heart Association.Circulation.2014; 129(9): 1048-1078, doi: 10.1161/01.cir.0000442577.96802.8c, indexed in Pubmed: 24548843.
Davies MG, Saad WE, Peden EK, et al.The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia.J Vasc Surg.2008; 48(4): 865-871, doi: 10.1016/j.jvs.2008.05.030, indexed in Pubmed: 18692345.
Mousa AY, Campbell JE, Stone PA, et al.Short- And long-term outcomes of percutaneous transluminal angioplasty/stenting of renal fibromuscular dysplasia over a ten-year period.J Vasc Surg.2012; 55(2): 421-427, doi: 10.1016/j.jvs.2011.09.006, indexed in Pubmed: 22112553.
Trinquart L, Mounier-Vehier C, Sapoval M, et al.Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: A systematic review and meta-analysis.Hypertension.2010; 56(3): 525-532, doi: 10.1161/HYPERTENSIONAHA.110.152918, indexed in Pubmed: 20625080.
Kane GC, Xu N, Mistrik E, et al.Renal artery revascularization improves heart failure control in patients with atherosclerotic renal artery stenosis.Nephrol Dial Transplant.2010; 25(3): 813-820, doi: 10.1093/ndt/gfp393, indexed in Pubmed: 19666661.
Ritchie J, Green D, Chrysochou C, et al.High-risk clinical presentations in atherosclerotic renovascular disease: Prognosis and response to renal artery revascularization.Am J Kidney Dis.2014; 63(2): 186-197, doi: 10.1053/j.ajkd.2013.07.020, indexed in Pubmed: 24074824.
Van den Berg DT, Deinum J, Postma CT, et al.The efficacy of renal angioplasty in patients with renal artery stenosis and flash oedema or congestive heart failure: A systematic review.Eur J Heart Fail.2012; 14(7): 773-781, doi: 10.1093/eurjhf/hfs037, indexed in Pubmed: 22455866.
Cianci R, Martina P, Borghesi F, et al.Revascularization versus medical therapy for renal artery stenosis: Antihypertensive drugs and renal outcome.Angiology.2011; 62(1): 92-99, doi: 10.1177/0003319710371615, indexed in Pubmed: 20547539.
Abela R, Ivanova S, Lidder S, et al.An analysis comparing open surgical and endovascular treatment of atherosclerotic renal artery stenosis.Eur J Vasc Endovasc Surg.2009; 38(6): 666-675, doi: 10.1016/j.ejvs.2009.08.002, indexed in Pubmed: 19726208.
Balzer KM, Neuschäfer S, Sagban TA, et al.Renal artery revascularization after unsuccessful percutaneous therapy: A single centre experience.Langenbecks Arch Surg.2012; 397(1): 111-115, doi: 10.1007/s00423-011-0857-9, indexed in Pubmed: 22006025.
Balzer KM, Pfeiffer T, Rossbach S, et al.Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD).J Vasc Surg.2009; 49(3): 667-74; discussion 674, doi: 10.1016/j.jvs.2008.10.006, indexed in Pubmed: 19135837.
McDermott MM, Greenland P, Liu K, et al.Leg symptoms in peripheral arterial disease: Associated clinical characteristics and functional impairment.JAMA.2001; 286(13): 1599-1606, indexed in Pubmed: 11585483.
Leng GC, Fowkes FG.The Edinburgh Claudication Questionnaire: An improved version of the WHO/Rose Questionnaire for use in epidemiological surveys.J Clin Epidemiol.1992; 45(10): 1101-1109, indexed in Pubmed: 1474406.
Norgren L, Hiatt WR, Dormandy JA, et al.TASC II Working Group.Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).J Vasc Surg.2007; 45 Suppl S: S5-67, doi: 10.1016/j.jvs.2006.12.037, indexed in Pubmed: 17223489.
Abou-Zamzam AM, Gomez NR, Molkara A, et al.A prospective analysis of critical limb ischemia: Factors leading to major primary amputation versus revascularization.Ann Vasc Surg.2007; 21(4): 458-463, doi: 10.1016/j.avsg.2006.12.006, indexed in Pubmed: 17499967.
Abu Dabrh AM, Steffen MW, Undavalli C, et al.The natural history of untreated severe or critical limb ischemia.J Vasc Surg.2015; 62(6): 1642-51.e3, doi: 10.1016/j.jvs.2015.07.065, indexed in Pubmed: 26391460.
Sigvant B, Lundin F, Wahlberg E.The Risk of Disease Progression in Peripheral Arterial Disease is Higher than Expected: A Meta- -Analysis of Mortality and Disease Progression in Peripheral Arterial Disease.Eur J Vasc Endovasc Surg.2016; 51(3): 395-403, doi: 10.1016/j.ejvs.2015.10.022, indexed in Pubmed: 26777541.
Xu D, Zou L, Xing Y, et al.Diagnostic value of ankle-brachial index in peripheral arterial disease: A meta-analysis.Can J Cardiol.2013; 29(4): 492-498, doi: 10.1016/j.cjca.2012.06.014, indexed in Pubmed: 22926041.
Aboyans V, Criqui MH, Abraham P, et al.Measurement and interpretation of the ankle-brachial index: A scientific statement from the American Heart Association.Circulation.2012; 126(24): 2890-2909, doi: 10.1161/CIR.0b013e318276fbcb, indexed in Pubmed: 23159553.
Tehan PE, Santos D, Chuter VH.A systematic review of the sensitivity and specificity of the toe-brachial index for detecting peripheral artery disease.Vasc Med.2016; 21(4): 382-389, doi: 10.1177/1358863X16645854, indexed in Pubmed: 27165712.
Collins R, Cranny G, Burch J, et al.A systematic review of duplex ultrasound, magnetic resonance angiography and computed tomography angiography for the diagnosis and assessment of symptomatic, lower limb peripheral arterial disease.Health Technol Assess.2007; 11(20): 1-184, indexed in Pubmed: 17462170.
Met R, Bipat S, Legemate DA, et al.Diagnostic performance of computed tomography angiography in peripheral arterial disease: A systematic review and meta-analysis.JAMA.2009; 301(4): 415- 424, doi: 10.1001/jama.301.4.415, indexed in Pubmed: 19176443.
Menke J, Larsen J.Meta-analysis: Accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease.Ann Intern Med.2010; 153(5): 325-334, doi: 10.7326/0003-4819-153-5-201009070-00007, indexed in Pubmed: 20820041.
Koelemay MJ, Lijmer JG, Stoker J, et al.Magnetic resonance angiography for the evaluation of lower extremity arterial disease: A meta-analysis.JAMA.2001; 285(10): 1338-1345, indexed in Pubmed: 11255390.
Ouwendijk R, de Vries M, Stijnen T, et al.Multicenter randomized controlled trial of the costs and effects of noninvasive diagnostic imaging in patients with peripheral arterial disease: The DIPAD trial.AJR Am J Roentgenol.2008; 190(5): 1349-1357, doi: 10.2214/AJR.07.3359, indexed in Pubmed: 18430854.
Barba A, Estallo L, Rodríguez L, et al.Detection of abdominal aortic aneurysm in patients with peripheral artery disease.Eur J Vasc Endovasc Surg.2005; 30(5): 504-508, doi: 10.1016/j.ejvs.2005.05.011, indexed in Pubmed: 15963741.
Giugliano G, Laurenzano E, Rengo C, et al.Abdominal aortic aneurysm in patients affected by intermittent claudication: Prevalence and clinical predictors.BMC Surg.2012; 12 Suppl 1: S17, doi: 10.1186/1471-2482-12-S1-S17, indexed in Pubmed: 23173942.
Juergens JL, Barker NW, Hines EA.Arteriosclerosis obliterans: Review of 520 cases with special reference to pathogenic and prognostic factors.Circulation.1960; 21: 188-195, indexed in Pubmed: 14408094.
Momsen AH, Jensen MB, Norager CB, et al.Drug therapy for improving walking distance in intermittent claudication: A systematic review and meta-analysis of robust randomised controlled studies.Eur J Vasc Endovasc Surg.2009; 38(4): 463-474, doi: 10.1016/j.ejvs.2009.06.002, indexed in Pubmed: 19586783.
Shahin Y, Barnes R, Barakat H, et al.Meta-analysis of angiotensin converting enzyme inhibitors effect on walking ability and ankle brachial pressure index in patients with intermittent claudication.Atherosclerosis.2013; 231(2): 283-290, doi: 10.1016/j.atherosclerosis.2013.09.037, indexed in Pubmed: 24267241.
Vlachopoulos C, Terentes-Printzios D, Aboyans V, et al.Angiotensin converting enzyme inhibitors and walking distance: Have we walked the whole distance? Atherosclerosis.2016; 252: 199-200, doi: 10.1016/j.atherosclerosis.2016.08.001, indexed in Pubmed: 27543007.
Bagger JP, Helligsoe P, Randsbaek F, et al.Effect of verapamil in intermittent claudication A randomized, double-blind, placebo-controlled, cross-over study after individual dose-response assessment.Circulation.1997; 95(2): 411-414, indexed in Pubmed: 9008458.
Espinola-Klein C, Weisser G, Jagodzinski A, et al.ß-Blockers in patients with intermittent claudication and arterial hypertension: Results from the nebivolol or metoprolol in arterial occlusive disease trial.Hypertension.2011; 58(2): 148-154, doi: 10.1161/HYPERTENSIONAHA.110.169169, indexed in Pubmed: 21646599.
Soga Y, Iida O, Takahara M, et al.Beta-blocker Treatment Does Not Worsen Critical Limb Ischemia in Patients Receiving Endovascular Therapy.J Atheroscler Thromb.2015; 22(5): 481-489, doi: 10.5551/jat.27359, indexed in Pubmed: 25445890.
Mirault T, Galloula A, Cambou JP, et al.Impact of betablockers on general and local outcome in patients hospitalized for lower extremity peripheral artery disease: The COPART Registry.Medicine (Baltimore).2017; 96(5): E5916, doi: 10.1097/MD.0000000000005916, indexed in Pubmed: 28151868.
Lane R, Ellis B, Watson L, et al.Exercise for intermittent claudication.Cochrane Database Syst Rev.2014(7): CD000990, doi: 10.1002/14651858.CD000990.pub3, indexed in Pubmed: 25037027.
Fokkenrood HJP, Bendermacher BLW, Lauret GJ, et al.Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication.Cochrane Database Syst Rev.2013(8): CD005263, doi: 10.1002/14651858.CD005263.pub3, indexed in Pubmed: 23970372.
Gommans LNM, Fokkenrood HJP, van Dalen HCW, et al.Safety of supervised exercise therapy in patients with intermittent claudication.J Vasc Surg.2015; 61(2): 512-518.e2, doi: 10.1016/j.jvs.2014.08.070, indexed in Pubmed: 25441008.
Bermingham SL, Sparrow K, Mullis R, et al.The Cost-effectiveness of Supervised Exercise for the Treatment of Intermittent Claudication.Eur J Vasc Endovasc Surg.2013; 46(6): 707-714, doi: 10.1016/j.ejvs.2013.09.005.
Al-Jundi W, Madbak K, Beard JD, et al.Systematic review of home- based exercise programmes for individuals with intermittent claudication.Eur J Vasc Endovasc Surg.2013; 46(6): 690-706, doi: 10.1016/j.ejvs.2013.09.004, indexed in Pubmed: 24076079.
Bäck M, Jivegard L, Johansson A, et al.Home-based supervised exercise versus hospital-based supervised exercise or unsupervised walk advice as treatment for intermittent claudication: A systematic review.J Rehabil Med.2015; 47(9): 801-808, doi: 10.2340/16501977-2012.
Lauret GJ, Fakhry F, Fokkenrood HJP, et al.Modes of exercise training for intermittent claudication.Cochrane Database Syst Rev.2014(7): CD009638, doi: 10.1002/14651858.CD009638.pub2, indexed in Pubmed: 24993079.
Jakubseviciene E, Vasiliauskas D, Velicka L, et al.Effectiveness of a new exercise program after lower limb arterial blood flow surgery in patients with peripheral arterial disease: A randomized clinical trial.Int J Environ Res Public Health.2014; 11(8): 7961-7976, doi: 10.3390/ijerph110807961, indexed in Pubmed: 25105547.
Kruidenier LM, Nicolaï SP, Rouwet EV, et al.Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: A randomized clinical trial.J Vasc Interv Radiol.2011; 22(7): 961-968, doi: 10.1016/j.jvir.2011.02.017, indexed in Pubmed: 21571547.
Gargiulo G, Giugliano G, Brevetti L, et al.Use of statins in lower extremity artery disease: A review.BMC Surg.2012; 12 Suppl 1: S15, doi: 10.1186/1471-2482-12-S1-S15, indexed in Pubmed: 23173874.
Giri J, McDermott MM, Greenland P, et al.Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease.Circulation.2003; 107(5): 757-761, indexed in Pubmed: 12578881.
Robertson L, Andras A.Prostanoids for intermittent claudication.Cochrane Database Syst Rev.2013(4): CD000986, doi: 10.1002/14651858.CD000986.pub3, indexed in Pubmed: 23633305.
Stevens JW, Simpson E, Harnan S, et al.Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.Br J Surg.2012; 99(12): 1630-1638, doi: 10.1002/bjs.8895, indexed in Pubmed: 23034699.
Indes JE, Pfaff MJ, Farrokhyar F, et al.Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: A systematic review and meta-analysis.J Endovasc Ther.2013; 20(4): 443-455, doi: 10.1583/13-4242.1, indexed in Pubmed: 23914850.
Grimme FAB, Goverde PC, Verbruggen PJ, et al.Editor's Choice- -First Results of the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) Technique for Aortoiliac Occlusive Disease.Eur J Vasc Endovasc Surg.2015; 50(5): 638-647, doi: 10.1016/j.ejvs.2015.06.112, indexed in Pubmed: 26343310.
Anderson JL, Antman EM, Harold JG, et al.Clinical practice guidelines on perioperative cardiovascular evaluation: Collaborative efforts among the ACC, AHA, and ESC.Circulation.2014; 130(24): 2213-2214, doi: 10.1161/CIR.0000000000000103, indexed in Pubmed: 25085963.
Klinkert P, Post PN, Breslau PJ, et al.Saphenous vein versus PTFE for above-knee femoropopliteal bypass.A review of the literature.Eur J Vasc Endovasc Surg.2004; 27(4): 357-362, doi: 10.1016/j.ejvs.2003.12.027, indexed in Pubmed: 15015183.
Malgor RD, Alahdab F, Alalahdab F, et al.A systematic review of treatment of intermittent claudication in the lower extremities.J Vasc Surg.2015; 61(3 Suppl): 54S-73S, doi: 10.1016/j.jvs.2014.12.007, indexed in Pubmed: 25721067.
Murphy TP, Cutlip DE, Regensteiner JG, et al.Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: Six-month outcomes from the claudication: Exercise versus endoluminal revascularization (CLEVER) study.Circulation.2012; 125(1): 130-139, doi: 10.1161/CIRCULATIONAHA.111.075770, indexed in Pubmed: 22090168.
Fokkenrood HJP, Bendermacher BLW, Lauret GJ, et al.Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication.Cochrane Database Syst Rev.2006(2): CD005263, doi: 10.1002/14651858.CD005263.pub2, indexed in Pubmed: 16625633.
Fakhry F, Spronk S, van der Laan L, et al.Endovascular Revascularization and Supervised Exercise for Peripheral Artery Disease and Intermittent Claudication: A Randomized Clinical Trial.JAMA.2015; 314(18): 1936-1944, doi: 10.1001/jama.2015.14851, indexed in Pubmed: 26547465.
Vemulapalli S, Dolor RJ, Hasselblad V, et al.Supervised vs unsupervised exercise for intermittent claudication: A systematic review and meta-analysis.Am Heart J.2015; 169(6): 924-937.e3, doi: 10.1016/j.ahj.2015.03.009, indexed in Pubmed: 26027632.
Greenhalgh RM, Belch JJF, Brown LC, et al.The adjuvant benefit of angioplasty in patients with mild to moderate intermittent claudication (MIMIC) managed by supervised exercise, smoking cessation advice and best medical therapy: Results from two randomised trials for stenotic femoropopliteal and aortoiliac arterial disease.Eur J Vasc Endovasc Surg.2008; 36(6): 680-688, doi: 10.1016/j.ejvs.2008.10.007, indexed in Pubmed: 19022184.
Jongkind V, Akkersdijk GJM, Yeung KK, et al.A systematic review of endovascular treatment of extensive aortoiliac occlusive disease.J Vasc Surg.2010; 52(5): 1376-1383, doi: 10.1016/j.jvs.2010.04.080, indexed in Pubmed: 20598474.
Ballotta E, Lorenzetti R, Piatto G, et al.Reconstructive surgery for complex aortoiliac occlusive disease in young adults.J Vasc Surg.2012; 56(6): 1606-1614, doi: 10.1016/j.jvs.2012.05.105, indexed in Pubmed: 23092642.
Bredahl K, Jensen LP, Schroeder TV, et al.Mortality and complications after aortic bifurcated bypass procedures for chronic aortoiliac occlusive disease.J Vasc Surg.2015; 62(1): 75-82, doi: 10.1016/j.jvs.2015.02.025, indexed in Pubmed: 26115920.
Bosiers M, Deloose K, Callaert J, et al.BRAVISSIMO: 12-month results from a large scale prospective trial.J Cardiovasc Surg (Torino).2013; 54(2): 235-253, indexed in Pubmed: 23558659.
Ye W, Liu CW, Ricco JB, et al.Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions.J Vasc Surg.2011; 53(6): 1728-1737, doi: 10.1016/j.jvs.2011.02.005, indexed in Pubmed: 21609804.
Goode SD, Cleveland TJ, Gaines PA, et al.Randomized clinical trial of stents versus angioplasty for the treatment of iliac artery occlusions (STAG trial).Br J Surg.2013; 100(9): 1148-1153, doi: 10.1002/bjs.9197, indexed in Pubmed: 23842828.
Antoniou GA, Sfyroeras GS, Karathanos C, et al.Hybrid endovascular and open treatment of severe multilevel lower extremity arterial disease.Eur J Vasc Endovasc Surg.2009; 38(5): 616-622, doi: 10.1016/j.ejvs.2009.06.016, indexed in Pubmed: 19616976.
Dosluoglu HH, Lall P, Cherr GS, et al.Role of simple and complex hybrid revascularization procedures for symptomatic lower extremity occlusive disease.J Vasc Surg.2010; 51(6): 1425-1435.e1, doi: 10.1016/j.jvs.2010.01.092, indexed in Pubmed: 20488323.
Kavanagh CM, Heidenreich MJ, Albright JJ, et al.Hybrid external iliac selective endarterectomy surgical technique and outcomes.J Vasc Surg.2016; 64(5): 1327-1334, doi: 10.1016/j.jvs.2016.03.468, indexed in Pubmed: 27478006.
Matsagkas M, Kouvelos G, Arnaoutoglou E, et al.Hybrid procedures for patients with critical limb ischemia and severe common femoral artery atherosclerosis.Ann Vasc Surg.2011; 25(8): 1063-1069, doi: 10.1016/j.avsg.2011.07.010, indexed in Pubmed: 22023941.
Crawford JD, Perrone KH, Wong VW, et al.A modern series of acute aortic occlusion.J Vasc Surg.2014; 59(4): 1044-1050, doi: 10.1016/j.jvs.2013.10.080, indexed in Pubmed: 24393282.
Lammer J, Zeller T, Hausegger KA, et al.Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: The VIASTAR trial.Cardiovasc Intervent Radiol.2015; 38(1): 25-32, doi: 10.1007/s00270-014-1024-9, indexed in Pubmed: 25472936.
Lammer J, Zeller T, Hausegger KA, et al.Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: The randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease).J Am Coll Cardiol.2013; 62(15): 1320-1327, doi: 10.1016/j.jacc.2013.05.079, indexed in Pubmed: 23831445.
Laird JR, Katzen BT, Scheinert D, et al.RESILIENT Investigators.Nitinol stent implantation vs.balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: Three-year follow-up from the RESILIENT randomized trial.J Endovasc Ther.2012; 19(1): 1-9, doi: 10.1583/11-3627.1, indexed in Pubmed: 22313193.
Schillinger M, Sabeti S, Dick P, et al.Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting.Circulation.2007; 115(21): 2745-2749, doi: 10.1161/CIRCULATIONAHA.107.688341, indexed in Pubmed: 17502568.
Liistro F, Grotti S, Porto I, et al.Drug-eluting balloon in peripheral intervention for the superficial femoral artery: The DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery).JACC Cardiovasc Interv.2013; 6(12): 1295-1302, doi: 10.1016/j.jcin.2013.07.010, indexed in Pubmed: 24239203.
Rosenfield K, Jaff MR, White CJ, et al.Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.N Engl J Med.2015; 373(2): 145-153, doi: 10.1056/NEJMoa1406235, indexed in Pubmed: 26106946.
Tepe G, Laird J, Schneider P, et al.Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial.Circulation.2015; 131(5): 495-502, doi: 10.1161/CIRCULATIONAHA.114.011004, indexed in Pubmed: 25472980.
Tepe G, Zeller T, Albrecht T, et al.Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg.N Engl J Med.2008; 358(7): 689-699, doi: 10.1056/NEJMoa0706356, indexed in Pubmed: 18272892.
Werk M, Albrecht T, Meyer DR, et al.Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: Evidence from the randomized PACIFIER trial.Circ Cardiovasc Interv.2012; 5(6): 831-840, doi: 10.1161/CIRCINTERVENTIONS.112.971630, indexed in Pubmed: 23192918.
Geraghty PJ, Mewissen MW, Jaff MR, et al.Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease.J Vasc Surg.2013; 58(2): 386-95.e4, doi: 10.1016/j.jvs.2013.01.050, indexed in Pubmed: 23676191.
Scheinert D, Werner M, Scheinert S, et al.Treatment of complex atherosclerotic popliteal artery disease with a new self-expanding interwoven nitinol stent: 12-month results of the Leipzig SUPERA popliteal artery stent registry.JACC Cardiovasc Interv.2013; 6(1): 65-71, doi: 10.1016/j.jcin.2012.09.011, indexed in Pubmed: 23347863.
Tosaka A, Soga Y, Iida O, et al.Classification and clinical impact of restenosis after femoropopliteal stenting.J Am Coll Cardiol.2012; 59(1): 16-23, doi: 10.1016/j.jacc.2011.09.036, indexed in Pubmed: 22192663.
Bradbury AW, Adam DJ, Bell J, et al.BASIL Trial Participants.Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: A survival prediction model to facilitate clinical decision making.J Vasc Surg.2010; 51(5 Suppl): 52S-68S, doi: 10.1016/j.jvs.2010.01.077, indexed in Pubmed: 20435262.
Arvela E, Venermo M, Söderström M, et al.Outcome of infrainguinal single-segment great saphenous vein bypass for critical limb ischemia is superior to alternative autologous vein bypass, especially in patients with high operative risk.Ann Vasc Surg.2012; 26(3): 396-403, doi: 10.1016/j.avsg.2011.08.013, indexed in Pubmed: 22285375.
Brass EP, Anthony R, Dormandy J, et al.Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia.J Vasc Surg.2006; 43(4): 752-759, doi: 10.1016/j.jvs.2005.11.041, indexed in Pubmed: 16616232.
Mills JL, Conte MS, Armstrong DG, et al.The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on wound, ischemia, and foot infection (WIfI).J Vasc Surg.2014; 59(1): 220-34.e2, doi: 10.1016/j.jvs.2013.08.003, indexed in Pubmed: 24126108.
Singh S, Armstrong EJ, Sherif W, et al.Association of elevated fasting glucose with lower patency and increased major adverse limb events among patients with diabetes undergoing infrapopliteal balloon angioplasty.Vasc Med.2014; 19(4): 307-314, doi: 10.1177/1358863X14538330, indexed in Pubmed: 24939930.
Takahara M, Kaneto H, Iida O, et al.The influence of glycemic control on the prognosis of Japanese patients undergoing percutaneous transluminal angioplasty for critical limb ischemia.Diabetes Care.2010; 33(12): 2538-2542, doi: 10.2337/dc10-0939, indexed in Pubmed: 20843974.
Dominguez A, Bahadorani J, Reeves R, et al.Endovascular therapy for critical limb ischemia.Expert Rev Cardiovasc Ther.2015; 13(4): 429-444, doi: 10.1586/14779072.2015.1019472, indexed in Pubmed: 25728744.
Lumsden AB, Davies MG, Peden EK.Medical and endovascular management of critical limb ischemia.J Endovasc Ther.2009; 16(2 Suppl 2): II31-II62, doi: 10.1583/08-2657.1, indexed in Pubmed: 19624074.
Manzi M, Palena L, Cester G.Endovascular techniques for limb salvage in diabetics with crural and pedal disease.J Cardiovasc Surg (Torino).2011; 52(4): 485-492, indexed in Pubmed: 21792156.
Adam DJ, Beard JD, Cleveland T, et al.Bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomised controlled trial.Lancet.2005; 366(9501): 1925-1934, doi: 10.1016/S0140-6736(05)67704-5, indexed in Pubmed: 16325694.
Zeller T, Baumgartner I, Scheinert D, et al.Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial.J Am Coll Cardiol.2014; 64(15): 1568-1576, doi: 10.1016/j.jacc.2014.06.1198, indexed in Pubmed: 25301459.
Menard M, Farber A.The BEST-CLI trial: A multidisciplinary effort to assess whether surgical or endovascular therapy is better for patients with critical limb ischemia.Semin Vasc Surg.2014; 27(1): 82-84, doi: 10.1053/j.semvascsurg.2015.01.003.
Popplewell MA, Davies H, Jarrett H, et al.Bypass versus angio plasty in severe ischaemia of the leg - 2 (BASIL-2) trial: Study protocol for a randomised controlled trial.Trials.2016; 17: 11, doi: 10.1186/s13063-015-1114-2, indexed in Pubmed: 26739146.
Teraa M, Conte MS, Moll FL, et al.Critical Limb Ischemia: Current Trends and Future Directions.J Am Heart Assoc.2016; 5(2), doi: 10.1161/JAHA.115.002938, indexed in Pubmed: 26908409.
Belch J, Hiatt WR, Baumgartner I, et al.Effect of fibroblast growth factor NV1FGF on amputation and death: A randomised placebo- -controlled trial of gene therapy in critical limb ischaemia.Lancet.2011; 377(9781): 1929-1937, doi: 10.1016/S0140-6736(11)60394-2, indexed in Pubmed: 21621834.
Moazzami K, Moazzami B, Roohi A, et al.Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.Cochrane Database Syst Rev.2014(12): CD008347, doi: 10.1002/14651858.CD008347.pub3, indexed in Pubmed: 25525690.
Peeters Weem SMO, Teraa M, de Borst GJ, et al.Bone Marrow derived Cell Therapy in Critical Limb Ischemia: A Meta-analysis of Randomized Placebo Controlled Trials.Eur J Vasc Endovasc Surg.2015; 50(6): 775-783, doi: 10.1016/j.ejvs.2015.08.018, indexed in Pubmed: 26460286.
Sobel M, Verhaeghe R.Antithrombotic therapy for peripheral artery occlusive disease: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines (8th Edition).Chest.2008; 133(6 Suppl): 815S-843S, doi: 10.1378/chest.08-0686, indexed in Pubmed: 18574279.
Rutherford RB, Baker JD, Ernst C, et al.Recommended standards for reports dealing with lower extremity ischemia: Revised version.J Vasc Surg.1997; 26(3): 517-538, indexed in Pubmed: 9308598.
Berridge DC, Kessel DO, Robertson I, et al.Surgery versus thrombolysis for acute limb ischaemia: Initial management.Cochrane Database Syst Rev.2000(4): CD002784, doi: 10.1002/14651858.CD002784, indexed in Pubmed: 11034762.
Savji N, Rockman CB, Skolnick AH, et al.Association between advanced age and vascular disease in different arterial territories: A population database of over 3.6 million subjects.J Am Coll Cardiol.2013; 61(16): 1736-1743, doi: 10.1016/j.jacc.2013.01.054, indexed in Pubmed: 23500290.
Aboyans V, Desormais I, Magne J, et al.Renal Artery Stenosis in Patients with Peripheral Artery Disease: Prevalence, Risk Factors and Long-term Prognosis.Eur J Vasc Endovasc Surg.2017; 53(3): 380-385, doi: 10.1016/j.ejvs.2016.10.029, indexed in Pubmed: 27919610.
Ahmed B, Al-Khaffaf H.Prevalence of significant asymptomatic carotid artery disease in patients with peripheral vascular disease: A meta-analysis.Eur J Vasc Endovasc Surg.2009; 37(3): 262-271, doi: 10.1016/j.ejvs.2008.10.017, indexed in Pubmed: 19058982.
Durand DJ, Perler BA, Roseborough GS, et al.Mandatory versus selective preoperative carotid screening: A retrospective analysis.Ann Thorac Surg.2004; 78(1): 159-66; discussion 159, doi: 10.1016/j.athoracsur.2004.02.024, indexed in Pubmed: 15223422.
Fowkes FG, Low LP, Tuta S, et al.Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: Results of the international AGATHA study.Eur Heart J.2006; 27(15): 1861-1867, doi: 10.1093/eurheartj/ehl114, indexed in Pubmed: 16820367.
Mukherjee D, Eagle KA, Kline-Rogers E, et al.Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events).Am J Cardiol.2007; 100(1): 1-6, doi: 10.1016/j.amjcard.2007.02.046, indexed in Pubmed: 17599431.
Naylor AR, Mehta Z, Rothwell PM, et al.Carotid artery disease and stroke during coronary artery bypass: A critical review of the literature.Eur J Vasc Endovasc Surg.2002; 23(4): 283-294, doi: 10.1053/ejvs.2002.1609, indexed in Pubmed: 11991687.
Steinvil A, Sadeh B, Arbel Y, et al.Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease.J Am Coll Cardiol.2011; 57(7): 779-783, doi: 10.1016/j.jacc.2010.09.047, indexed in Pubmed: 21310312.
Subherwal S, Bhatt DL, Li S, et al.Polyvascular disease and long-term cardiovascular outcomes in older patients with non- -ST-segment-elevation myocardial infarction.Circ Cardiovasc Qual Outcomes.2012; 5(4): 541-549, doi: 10.1161/CIRCOUTCOMES.111.964379, indexed in Pubmed: 22715460.
Collet JP, Cayla G, Ennezat PV, et al.Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA Study (submitted).
Lin JC, Kabbani LS, Peterson EL, et al.Clinical utility of carotid duplex ultrasound prior to cardiac surgery.J Vasc Surg.2016; 63(3): 710-714, doi: 10.1016/j.jvs.2015.10.008, indexed in Pubmed: 26916583.
Naylor AR, Bown MJ.Stroke after cardiac surgery and its association with asymptomatic carotid disease: An updated systematic review and meta-analysis.Eur J Vasc Endovasc Surg.2011; 41(5): 607-624, doi: 10.1016/j.ejvs.2011.02.016, indexed in Pubmed: 21396854.
Schoof J, Lubahn W, Baeumer M, et al.Impaired cerebral autoregulation distal to carotid stenosis/occlusion is associated with increased risk of stroke at cardiac surgery with cardiopulmonary bypass.J Thorac Cardiovasc Surg.2007; 134(3): 690-696, doi: 10.1016/j.jtcvs.2007.03.018, indexed in Pubmed: 17723819.
Stamou SC, Hill PC, Dangas G, et al.Stroke After Coronary Artery Bypass : Incidence, Predictors, and Clinical Outcome Editorial Comment: Incidence, Predictors, and Clinical Outcome.Stroke.2001; 32(7): 1508-1513, doi: 10.1161/01.str.32.7.1508.
Naylor AR.Delay may reduce procedural risk, but at what price to the patient? Eur J Vasc Endovasc Surg.2008; 35(4): 383-391, doi: 10.1016/j.ejvs.2008.01.002, indexed in Pubmed: 18261942.
Lamy A, Devereaux PJ, Prabhakaran D, et al.Off-pump or on-pump coronary-artery bypass grafting at 30 days.N Engl J Med.2012; 366(16): 1489-1497, doi: 10.1056/NEJMoa1200388, indexed in Pubmed: 22449296.
Illuminati G, Ricco JB, Caliò F, et al.Short-term results of a randomized trial examining timing of carotid endarterectomy in patients with severe asymptomatic unilateral carotid stenosis undergoing coronary artery bypass grafting.J Vasc Surg.2011; 54(4): 993-9; discussion 998, doi: 10.1016/j.jvs.2011.03.284, indexed in Pubmed: 21703806.
Randall MS, McKevitt FM, Cleveland TJ, et al.Is there any benefit from staged carotid and coronary revascularization using carotid stents? A single-center experience highlights the need for a randomized controlled trial.Stroke.2006; 37(2): 435-439, doi: 10.1161/01.
Van der Heyden J, Suttorp MJ, Bal ET, et al.Staged carotid angioplasty and stenting followed by cardiac surgery in patients with severe asymptomatic carotid artery stenosis: Early and long-term results.Circulation.2007; 116(18): 2036-2042, doi: 10.1161/CIRCULATIONAHA.106.658625, indexed in Pubmed: 17938290.
Versaci F, Del Giudice C, Scafuri A, et al.Sequential hybrid carotid and coronary artery revascularization: Immediate and mid-term results.Ann Thorac Surg.2007; 84(5): 1508-13; discussion 1513, doi: 10.1016/j.athoracsur.2007.05.048, indexed in Pubmed: 17954054.
Chiariello L, Nardi P, Pellegrino A, et al.Simultaneous carotid artery stenting and heart surgery: Expanded experience of hybrid surgical procedures.Ann Thorac Surg.2015; 99(4): 1291-1297, doi: 10.1016/j.athoracsur.2014.11.043, indexed in Pubmed: 25661578.
Shishehbor MH, Venkatachalam S, Sun Z, et al.A direct comparison of early and late outcomes with three approaches to carotid revascularization and open heart surgery.J Am Coll Cardiol.2013; 62(21): 1948-1956, doi: 10.1016/j.jacc.2013.03.094, indexed in Pubmed: 23876675.
Aboyans V, Lacroix P.Indications for carotid screening in patients with coronary artery disease.Presse Med.2009; 38(6): 977-986, doi: 10.1016/j.lpm.2009.02.015, indexed in Pubmed: 19376684.
Naylor AR, Cuffe RL, Rothwell PM, et al.A systematic review of outcomes following staged and synchronous carotid endarterectomy and coronary artery bypass.Eur J Vasc Endovasc Surg.2003; 25(5): 380-389, doi: 10.1053/ejvs.2002.1895, indexed in Pubmed: 12713775.
Paraskevas KI, Nduwayo S, Saratzis AN, et al.Carotid Stenting Prior to Coronary Bypass Surgery: An Updated Systematic Review and Meta-Analysis.Eur J Vasc Endovasc Surg.2017; 53(3): 309-319, doi: 10.1016/j.ejvs.2016.12.019, indexed in Pubmed: 28094166.
Imori Y, Akasaka T, Ochiai T, et al.Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery disease.Am J Cardiol.2014; 113(1): 30-35, doi: 10.1016/j.amjcard.2013.09.015, indexed in Pubmed: 24157190.
Kim EK, Song PS, Yang JH, et al.Peripheral artery disease in korean patients undergoing percutaneous coronary intervention: Prevalence and association with coronary artery disease severity.J Korean Med Sci.2013; 28(1): 87-92, doi: 10.3346/jkms.2013.28.1.87, indexed in Pubmed: 23341717.
Hussein AA, Uno K, Wolski K, et al.Peripheral arterial disease and progression of coronary atherosclerosis.J Am Coll Cardiol.2011; 57(10): 1220-1225, doi: 10.1016/j.jacc.2010.10.034, indexed in Pubmed: 21371639.
Eagle KA, Rihal CS, Foster ED, et al.Long-term survival in patients with coronary artery disease: Importance of peripheral vascular disease.The Coronary Artery Surgery Study (CASS) Investigators.J Am Coll Cardiol.1994; 23(5): 1091-1095, indexed in Pubmed: 8144774.
Grenon SM, Vittinghoff E, Owens CD, et al.Peripheral artery disease and risk of cardiovascular events in patients with coronary artery disease: Insights from the Heart and Soul Study.Vasc Med.2013; 18(4): 176-184, doi: 10.1177/1358863X13493825, indexed in Pubmed: 23835937.
Saw J, Bhatt DL, Moliterno DJ, et al.The influence of peripheral arterial disease on outcomes: A pooled analysis of mortality in eight large randomized percutaneous coronary intervention trials.J Am Coll Cardiol.2006; 48(8): 1567-1572, doi: 10.1016/j.jacc.2006.03.067, indexed in Pubmed: 17045889.
Aboyans V, Lacroix P, Postil A, et al.Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting.J Am Coll Cardiol.2005; 46(5): 815-820, doi: 10.1016/j.jacc.2005.05.066, indexed in Pubmed: 16139130.
Rihal CS, Sutton-Tyrrell K, Guo P, et al.Increased Incidence of Periprocedural Complications Among Patients With Peripheral Vascular Disease Undergoing Myocardial Revascularization in the Bypass Angioplasty Revascularization Investigation.Circulation.1999; 100(2): 171-177, doi: 10.1161/01.cir.100.2.171.
Hlatky MA, Boothroyd DB, Baker L, et al.Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: A cohort study.Ann Intern Med.2013; 158(10): 727-734, doi: 10.7326/0003-4819-158-10- 201305210-00639, indexed in Pubmed: 23609014.
Farooq V, van Klaveren D, Steyerberg EW, et al.Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: Development and validation of SYNTAX score II.Lancet.2013; 381(9867): 639-650, doi: 10.1016/S0140- 6736(13)60108-7, indexed in Pubmed: 23439103.
Dencker D, Pedersen F, Engstrøm T, et al.Major femoral vascular access complications after coronary diagnostic and interventional procedures: A Danish register study.Int J Cardiol.2016; 202: 604-608, doi: 10.1016/j.ijcard.2015.09.018, indexed in Pubmed: 26447671.
Neufang A, Dorweiler B, Espinola-Klein C, et al.Outcomes of complex femorodistal sequential autologous vein and biologic prosthesis composite bypass grafts.J Vasc Surg.2014; 60(6): 1543-1553, doi: 10.1016/j.jvs.2014.07.103, indexed in Pubmed: 25238725.
Spronk S, White JV, Ryjewski C, et al.Invasive treatment of claudication is indicated for patients unable to adequately ambulate during cardiac rehabilitation.J Vasc Surg.2009; 49(5): 1217-25; discussion 1225, doi: 10.1016/j.jvs.2008.11.066, indexed in Pubmed: 19394551.
Aboyans V, Lacroix P, Guilloux J, et al.A predictive model for screening cerebrovascular disease in patient undergoing coronary artery bypass grafting.Interact Cardiovasc Thorac Surg.2005; 4(2): 90-95, doi: 10.1510/icvts.2004.092262, indexed in Pubmed: 17670364.
Valgimigli M, Gagnor A, Calabró P, et al.Radial versus femoral access in patients with acute coronary syndromes undergoing invasive management: A randomised multicentre trial.Lancet.2015; 385(9986): 2465-2476, doi: 10.1016/S0140-6736(15)60292-6, indexed in Pubmed: 25791214.
Jones WS, Clare R, Ellis SJ, et al.Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION).Am J Cardiol.2011; 108(3): 380-384, doi: 10.1016/j.amjcard.2011.03.057, indexed in Pubmed: 21565325.
Inglis SC, Bebchuk J, Al-Suhaim SA, et al.Peripheral artery disease and outcomes after myocardial infarction: An individual- patient meta-analysis of 28,771 patients in CAPRICORN, EPEHESUS, OPTIMAAL and VALIANT.Int J Cardiol.2013; 168(2): 1094-1101, doi: 10.1016/j.ijcard.2012.11.033, indexed in Pubmed: 23194780.
Nakamura Y, Kunii H, Yoshihisa A, et al.Impact of peripheral artery disease on prognosis in hospitalized heart failure patients.Circ J.2015; 79(4): 785-793, doi: 10.1253/circj.CJ-14-1280, indexed in Pubmed: 25739573.
Van Straten AHM, Firanescu C, Soliman Hamad MA, et al.Peripheral vascular disease as a predictor of survival after coronary artery bypass grafting: Comparison with a matched general population.Ann Thorac Surg.2010; 89(2): 414-420, doi: 10.1016/j.athoracsur.2009.11.036, indexed in Pubmed: 20103313.
Calvet D, Touzé E, Varenne O, et al.Prevalence of asymptomatic coronary artery disease in ischemic stroke patients: The PRECORIS study.Circulation.2010; 121(14): 1623-1629, doi: 10.1161/CIRCULATIONAHA.109.906958, indexed in Pubmed: 20351236.
Hofmann R, Kypta A, Steinwender C, et al.Coronary angiography in patients undergoing carotid artery stenting shows a high incidence of significant coronary artery disease.Heart.2005; 91(11): 1438-1441, doi: 10.1136/hrt.2004.050906, indexed in Pubmed: 15761052.
Illuminati G, Ricco JB, Greco C, et al.Systematic preoperative coronary angiography and stenting improves postoperative results of carotid endarterectomy in patients with asymptomatic coronary artery disease: A randomised controlled trial.Eur J Vasc Endovasc Surg.2010; 39(2): 139-145, doi: 10.1016/j.ejvs.2009.11.015, indexed in Pubmed: 20005750.
Illuminati G, Schneider F, Greco C, et al.Long-term results of a randomized controlled trial analyzing the role of systematic pre-operative coronary angiography before elective carotid endarterectomy in patients with asymptomatic coronary artery disease.Eur J Vasc Endovasc Surg.2015; 49(4): 366-374, doi: 10.1016/j.ejvs.2014.12.030, indexed in Pubmed: 25701070.
Vidakovic R, Schouten O, Kuiper R, et al.The prevalence of polyvascular disease in patients referred for peripheral arterial disease.Eur J Vasc Endovasc Surg.2009; 38(4): 435-440, doi: 10.1016/j.ejvs.2009.05.006, indexed in Pubmed: 19560948.
Hur DJ, Kizilgul M, Aung WW, et al.Frequency of coronary artery disease in patients undergoing peripheral artery disease surgery.Am J Cardiol.2012; 110(5): 736-740, doi: 10.1016/j.amjcard.2012.04.059, indexed in Pubmed: 22633203.
Ishihara T, Iida O, Tosaka A, et al.Severity of coronary artery disease affects prognosis of patients with peripheral artery disease.Angiology.2013; 64(6): 417-422, doi: 10.1177/0003319712452627, indexed in Pubmed: 22773383.
Kristensen SD, Knuuti J, Saraste A, et al.2014 ESC/ESA Guidelines on non-cardiac surgery: Cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: Cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).Eur J Anaesthesiol.2014; 31(10): 517-573, doi: 10.1097/EJA.0000000000000150, indexed in Pubmed: 25127426.
Gallino A, Aboyans V, Diehm C, et al.Non-coronary atherosclerosis.Eur Heart J.2014; 35(17): 1112-1119, doi: 10.1093/eurheartj/ehu071, indexed in Pubmed: 24595865.
Cho I, Chang HJ, Sung JiM, et al.Coronary computed tomographic angiography and risk of all-cause mortality and nonfatal myocardial infarction in subjects without chest pain syndrome from the CONFIRM Registry (coronary CT angiography evaluation for clinical outcomes: An international multicenter registry).Circulation.2012; 126(3): 304-313, doi: 10.1161/CIRCULATIONAHA.111.081380, indexed in Pubmed: 22685117.
Bhatt DL, Peterson ED, Harrington RA, et al.Prior polyvascular disease: Risk factor for adverse ischaemic outcomes in acute coronary syndromes.Eur Heart J 2009; 30(10): 1195-1202, doi: 10.1093/eurheartj/ehp099.
Montalescot G, Sechtem U, Achenbach S, et al.2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology.Eur Heart J.2013; 34(38): 2949-3003, doi: 10.1093/eurheartj/eht296, indexed in Pubmed: 23996286.
Sirimarco G, Amarenco P, Labreuche J, et al.Carotid atherosclerosis and risk of subsequent coronary event in outpatients with atherothrombosis.Stroke.2013; 44(2): 373-379, doi: 10.1161/STROKEAHA.112.673129, indexed in Pubmed: 23306325.
Amighi J, Schlager O, Haumer M, et al.Renal artery stenosis predicts adverse cardiovascular and renal outcome in patients with peripheral artery disease.Eur J Clin Invest.2009; 39(9): 784-792, doi: 10.1111/j.1365-2362.2009.02180.x, indexed in Pubmed: 19522837.
Rauchhaus M, Doehner W, Francis DP, et al.Plasma cytokine parameters and mortality in patients with chronic heart failure.Circulation.2000; 102(25): 3060-3067, indexed in Pubmed: 11120695.
Kahan T.The importance of myocardial fibrosis in hypertensive heart disease.J Hypertens.2012; 30(4): 685-687, doi: 10.1097/HJH.0b013e328350e5db, indexed in Pubmed: 22418905.
O'Rourke MF, Safar ME, Dzau V.The Cardiovascular Continuum extended: Aging effects on the aorta and microvasculature.Vasc Med.2010; 15(6): 461-468, doi: 10.1177/1358863X10382946, indexed in Pubmed: 21056945.
Duscha BD, Annex BH, Green HJ, et al.Deconditioning fails to explain peripheral skeletal muscle alterations in men with chronic heart failure.J Am Coll Cardiol.2002; 39(7): 1170-1174, indexed in Pubmed: 11923042.
Mancini DM, Walter G, Reichek N, et al.Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure.Circulation.1992; 85(4): 1364-1373, indexed in Pubmed: 1555280.
Hedberg P, Hammar C, Selmeryd J, et al.Left ventricular systolic dysfunction in outpatients with peripheral atherosclerotic vascular disease: Prevalence and association with location of arterial disease.Eur J Heart Fail.2014; 16(6): 625-632, doi: 10.1002/ejhf.95.
Ponikowski P, Voors AA, Anker SD, et al.2016 ESC Guidelines for the diagno- sis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC).Developed with the special contribu- tion of the Heart Failure Association (HFA) of the ESC.Eur J Heart Fail.2016; 18: 891-975.
Yamasaki S, Izawa A, Shiba Y, et al.Presence of diastolic dysfunction in patients with peripheral artery disease.Angiology.2013; 64(7): 540-543, doi: 10.1177/0003319713476135, indexed in Pubmed: 23401627.
Meltzer AJ, Shrikhande G, Gallagher KA, et al.Heart failure is associated with reduced patency after endovascular intervention for symptomatic peripheral arterial disease.J Vasc Surg.2012; 55(2): 353-362, doi: 10.1016/j.jvs.2011.08.016, indexed in Pubmed: 22051874.
Inglis S, Hermis A, Shehab S, et al.Peripheral arterial disease and chronic heart failure: A dangerous mix.Heart Failure Reviews.2012; 18(4): 457-464, doi: 10.1007/s10741-012-9331-1.
Inglis SC, McMurray JJV, Böhm M, et al.Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: Analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).Eur J Heart Fail.2010; 12(7): 698- 705, doi: 10.1093/eurjhf/hfq070, indexed in Pubmed: 20501489.
Ahmed MI, Aronow WS, Criqui MH, et al.Effects of peripheral arterial disease on outcomes in advanced chronic systolic heart failure: A propensity-matched study.Circ Heart Fail.2010; 3(1): 118-124, doi: 10.1161/CIRCHEARTFAILURE.109.866558, indexed in Pubmed: 19861658.
Go AS, Hylek EM, Phillips KA, et al.Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.JAMA.2001; 285(18): 2370-2375, indexed in Pubmed: 11343485.
Griffin WF, Salahuddin T, O'Neal WT, et al.Peripheral arterial disease is associated with an increased risk of atrial fibrillation in the elderly.Europace.2016; 18(6): 794-798, doi: 10.1093/europace/euv369, indexed in Pubmed: 26589625.
Aboyans V, Lacroix P, Echahidi N, et al.Ankle-brachial index in patients with nonvalvular atrial fibrillation.J Am Coll Cardiol.2014; 63(14): 1456-1457, doi: 10.1016/j.jacc.2013.09.071, indexed in Pubmed: 24315898.
Gallego P, Roldán V, Marín F, et al.Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation.Eur J Clin Invest.2012; 42(12): 1302-1308, doi: 10.1111/eci.12004, indexed in Pubmed: 23057651.
O'Neal WT, Efird JT, Nazarian S, et al.Peripheral arterial disease and risk of atrial fibrillation and stroke: The Multi-Ethnic Study of Atherosclerosis.J Am Heart Assoc.2014; 3(6): E001270, doi: 10.1161/JAHA.114.001270, indexed in Pubmed: 25404190.
Wasmer K, Unrath M, Köbe J, et al.Atrial fibrillation is a risk marker for worse in-hospital and long-term outcome in patients with peripheral artery disease.Int J Cardiol.2015; 199: 223-228, doi: 10.1016/j.ijcard.2015.06.094, indexed in Pubmed: 26209823.
Gilard M, Eltchaninoff H, Iung B, et al.Registry of transcatheter aortic-valve implantation in high-risk patients.N Engl J Med.2012; 366(18): 1705-1715, doi: 10.1056/NEJMoa1114705, indexed in Pubmed: 22551129.
Leon MB, Smith CR, Mack M, et al.Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.N Engl J Med.2010; 363(17): 1597-1607, doi: 10.1056/NEJMoa1008232, indexed in Pubmed: 20961243.
Skelding KA, Yakubov SJ, Kleiman NS, et al.Transcatheter Aortic Valve Replacement Versus Surgery in Women at High Risk for Surgical Aortic Valve Replacement (from the CoreValve US High Risk Pivotal Trial).Am J Cardiol.2016; 118(4): 560-566, doi: 10.1016/j.amjcard.2016.05.051, indexed in Pubmed: 27381665.
Aronow W.Peripheral arterial disease in the elderly.Clinical Interventions in Aging.2008; Volume 2: 645-654, doi: 10.2147/cia.s2412.
Adams DH, Popma JJ, Reardon MJ.Transcatheter aortic-valve replacement with a self-expanding prosthesis.N Engl J Med.2014; 371(10): 967-968, doi: 10.1056/NEJMc1408396, indexed in Pubmed: 25184874.
Smith CR, Leon MB, Mack MJ, et al.PARTNER Trial Investigators.Transcatheter versus surgical aortic-valve replacement in high-risk patients.N Engl J Med.2011; 364(23): 2187-2198, doi: 10.1056/NEJMoa1103510, indexed in Pubmed: 21639811.
Sinning JM, Horack M, Grube E, et al.The impact of peripheral arterial disease on early outcome after transcatheter aortic valve implantation: Results from the German Transcatheter Aortic Valve Interventions Registry.Am Heart J.2012; 164(1): 102-110.e1, doi: 10.1016/j.ahj.2012.04.016, indexed in Pubmed: 22795289.
Erdogan HB, Goksedef D, Erentug V, et al.In which patients should sheathless IABP be used? An analysis of vascular complications in 1211 cases.J Card Surg.2006; 21(4): 342-346, doi: 10.1111/j.1540- -8191.2006.00268.x, indexed in Pubmed: 16846410.
Ohman JW, Vemuri C, Prasad S, et al.The effect of extremity vascular complications on the outcomes of cardiac support device recipients.J Vasc Surg.2014; 59(6): 1622-1627, doi: 10.1016/j.jvs.2013.12.014, indexed in Pubmed: 24447540.
de Weerd M, Greving JP, de Jong AWF, et al.Prevalence of asymptomatic carotid artery stenosis according to age and sex: Systematic review and metaregression analysis.Stroke.2009; 40(4): 1105-1113, doi: 10.1161/STROKEAHA.108.532218, indexed in Pubmed: 19246704.
Razzouk L, Rockman CB, Patel MR, et al.Co-existence of vascular disease in different arterial beds: Peripheral artery disease and carotid artery stenosis-Data from Life Line Screening(®).Atherosclerosis.2015; 241(2): 687-691, doi: 10.1016/j.atherosclerosis.2015.06.029, indexed in Pubmed: 26122189.
Osborn LA, Vernon SM, Reynolds B, et al.Screening for subclavian artery stenosis in patients who are candidates for coronary bypass surgery.Catheter Cardiovasc Interv.2002; 56(2): 162-165, doi: 10.1002/ccd.10198, indexed in Pubmed: 12112906.
Shadman R, Criqui MH, Bundens WP, et al.Subclavian artery stenosis: Prevalence, risk factors, and association with cardiovascular diseases.J Am Coll Cardiol.2004; 44(3): 618-623, doi: 10.1016/j.jacc.2004.04.044, indexed in Pubmed: 15358030.
Hansen KJ, Wilson DB, Craven TE, et al.Mesenteric artery disease in the elderly.J Vasc Surg.2004; 40(1): 45-52, doi: 10.1016/j.jvs.2004.03.022, indexed in Pubmed: 15218461.
Bageacu S, Cerisier A, Isaaz K, et al.Incidental visceral and renal artery stenosis in patients undergoing coronary angiography.Eur J Vasc Endovasc Surg.2011; 41(3): 385-390, doi: 10.1016/j.ejvs.2010.11.014, indexed in Pubmed: 21236708.
Valentine RJ, Martin JD, Myers SI, et al.Asymptomatic celiac and superior mesenteric artery stenoses are more prevalent among patients with unsuspected renal artery stenoses.J Vasc Surg.1991; 14(2): 195-199, doi: 10.1067/mva.1991.29423, indexed in Pubmed: 1861331.
Hansen KJ, Edwards MS, Craven TE, et al.Prevalence of renovascular disease in the elderly: A population-based study.J Vasc Surg.2002; 36(3): 443-451, doi: 10.1067/mva.2002.127351, indexed in Pubmed: 12218965.
Fowkes FG, Rudan D, Rudan I, et al.Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis.Lancet.2013; 382(9901): 1329-1340, doi: 10.1016/S0140-6736(13)61249-0, indexed in Pubmed: 23915883.
Diehm C, Schuster A, Allenberg JR, et al.High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: Cross-sectional study.Atherosclerosis.2004; 172(1): 95-105, doi: 10.1016/s0021-9150(03)00204-1, indexed in Pubmed: 14709362.
Grøndal N, Søgaard R, Lindholt JS.Baseline prevalence of abdominal aortic aneurysm, peripheral arterial disease and hypertension in men aged 65-74 years from a population screening study (VIVA trial).Br J Surg.2015; 102(8): 902-906, doi: 10.1002/bjs.9825, indexed in Pubmed: 25923784.
Sigvant B, Wiberg-Hedman K, Bergqvist D, et al.A population- -based study of peripheral arterial disease prevalence with special focus on critical limb ischemia and sex differences.J Vasc Surg.2007; 45(6): 1185-1191, doi: 10.1016/j.jvs.2007.02.004, indexed in Pubmed: 17543683.
Norgren L, Hiatt WR, Dormandy JA, et al.TASC II Working Group.Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).J Vasc Surg.2007; 45 Suppl S: S5-67, doi: 10.1016/j.jvs.2006.12.037, indexed in Pubmed: 17223489.
Criqui MH, Aboyans V.Epidemiology of peripheral artery disease.Circ Res.2015; 116(9): 1509-1526, doi: 10.1161/CIRCRESAHA.116.303849, indexed in Pubmed: 25908725.
Hooi JD, Kester AD, Stoffers HE, et al.Incidence of and risk factors for asymptomatic peripheral arterial occlusive disease: A longitudinal study.Am J Epidemiol.2001; 153(7): 666-672, indexed in Pubmed: 11282794.
Sampson UKA, Fowkes FG, McDermott MM, et al.Global and regional burden of death and disability from peripheral artery disease: 21 world regions, 1990 to 2010.Glob Heart.2014; 9(1): 145-158.e21, doi: 10.1016/j.gheart.2013.12.008, indexed in Pubmed: 25432124.
Högberg D, Kragsterman B, Björck M, et al.Carotid artery atherosclerosis among 65-year-old Swedish men - A population-based screening study.Eur J Vasc Endovasc Surg.2014; 48(1): 5-10, doi: 10.1016/j.ejvs.2014.02.004, indexed in Pubmed: 24631197.
de Weerd M, Greving JP, Hedblad Bo, et al.Prediction of asymptomatic carotid artery stenosis in the general population: Identification of high-risk groups.Stroke.2014; 45(8): 2366-2371, doi: 10.1161/STROKEAHA.114.005145, indexed in Pubmed: 24994719.
West HW, Juonala M, Gall SL, et al.Exposure to parental smoking in childhood is associated with increased risk of carotid atherosclerotic plaque in adulthood: The Cardiovascular Risk in Young Finns Study.Circulation.2015; 131(14): 1239-1246, doi: 10.1161/CIRCULATIONAHA.114.013485, indexed in Pubmed: 25802269.
Herder M, Johnsen SH, Arntzen KA, et al.Risk factors for progression of carotid intima-media thickness and total plaque area: A 13-year follow-up study: The Tromsø Study.Stroke.2012; 43(7): 1818-1823, doi: 10.1161/STROKEAHA.111.646596, indexed in Pubmed: 22550052.
Redgrave JNE, Lovett JK, Rothwell PM.Histological features of symptomatic carotid plaques in relation to age and smoking: The oxford plaque study.Stroke.2010; 41(10): 2288-2294, doi: 10.1161/STROKEAHA.110.587006, indexed in Pubmed: 20814007.
Tobe SW, Burgess E, Lebel M.Atherosclerotic renovascular disease.Can J Cardiol.2006; 22(7): 623-628, doi: 10.1016/s0828- -282x(06)70286-0, indexed in Pubmed: 16755319.
Slovut DP, Olin JW, Slovut DP, et al.Fibromuscular dysplasia.N Engl J Med.2004; 350(18): 1862-1871, doi: 10.1056/NEJMra032393, indexed in Pubmed: 15115832.
Joosten MM, Pai JK, Bertoia ML, et al.Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men.JAMA.2012; 308(16): 1660-1667, doi: 10.1001/jama.2012.13415, indexed in Pubmed: 23093164.
Bots ML, Breslau PJ, Briët E, et al.Cardiovascular determinants of carotid artery disease.The Rotterdam Elderly Study.Hypertension.1992; 19(6 Pt 2): 717-720, doi: 10.1161/01.hyp.19.6.717, indexed in Pubmed: 1592472.
Mathiesen E, Joakimsen O, Bønaa K.Prevalence of and Risk Factors Associated with Carotid Artery Stenosis: The Tromsø Study.Cerebrovasc Dis.2001; 12(1): 44-51, doi: 10.1159/000047680.
O'Leary DH, Polak JF, Kronmal RA, et al.Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study.The CHS Collaborative Research Group.Stroke.1992; 23(12): 1752-1760, doi: 10.1161/01.str.23.12.1752.
Chrysochou C, Kalra PA.Epidemiology and natural history of atherosclerotic renovascular disease.Prog Cardiovasc Dis.2009; 52(3): 184-195, doi: 10.1016/j.pcad.2009.09.001, indexed in Pubmed: 19917329.
Garg PK, Biggs ML, Carnethon M, et al.Metabolic syndrome and risk of incident peripheral artery disease: The cardiovascular health study.Hypertension.2014; 63(2): 413-419, doi: 10.1161/HYPERTENSIONAHA.113.01925, indexed in Pubmed: 24191289.
Emdin CA, Anderson SG, Callender T, et al.Usual blood pressure, peripheral arterial disease, and vascular risk: Cohort study of 4.2 million adults.BMJ.2015; 351: H4865, indexed in Pubmed: 26419648.
Howard DP, Banerjee A, Fairhead JF, et al.Population-based study of incidence, risk factors, outcome, and prognosis of is- chemic peripheral arterial events: Implications for prevention.Circulation.2015; 132(19): 1805-1815, doi: 10.1161/circulationaha.115.016424.
Allison MA, Criqui MH, McClelland RL, et al.The effect of novel cardiovascular risk factors on the ethnic-specific odds for peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis (MESA).J Am Coll Cardiol.2006; 48(6): 1190-1197, doi: 10.1016/j.jacc.2006.05.049, indexed in Pubmed: 16979004.
Meijer WT, Grobbee DE, Hunink MG, et al.Determinants of peripheral arterial disease in the elderly: The Rotterdam study.Arch Intern Med.2000; 160(19): 2934-2938, doi: 10.1001/archinte.160.19.2934, indexed in Pubmed: 11041900.
Newman AB, Siscovick DS, Manolio TA, et al.Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study.Cardiovascular Heart Study (CHS) Collaborative Research Group.Circulation.1993; 88(3): 837-845, doi: 10.1161/01.cir.88.3.837, indexed in Pubmed: 8353913.
Ridker PM, Stampfer MJ, Rifai N.Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease.JAMA.2001; 285(19): 2481-2485, doi: 10.1001/jama.285.19.2481, indexed in Pubmed: 11368701.
Murabito JM, Evans JC, Nieto K, et al.Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study.Am Heart J.2002; 143(6): 961-965, doi: 10.1067/mhj.2002.122871, indexed in Pubmed: 12075249.
Aboyans V, Criqui MH, Denenberg JO, et al.Risk factors for progression of peripheral arterial disease in large and small vessels.Circulation.2006; 113(22): 2623-2629, doi: 10.1161/CIRCULATIONAHA.105.608679, indexed in Pubmed: 16735675.
Laschkolnig A, Kollerits B, Lamina C, et al.Lipoprotein (a) concentrations, apolipoprotein (a) phenotypes, and peripheral arterial disease in three independent cohorts.Cardiovasc Res.2014; 103(1): 28-36, doi: 10.1093/cvr/cvu107, indexed in Pubmed: 24760552.
Scholtes VPW, Peeters W, van Lammeren GW, et al.Type 2 diabetes is not associated with an altered plaque phenotype among patients undergoing carotid revascularization.A histological analysis of 1455 carotid plaques.Atherosclerosis.2014; 235(2): 418-423, doi: 10.1016/j.atherosclerosis.2014.05.941, indexed in Pubmed: 24937465.
Jude EB, Oyibo SO, Chalmers N, et al.Peripheral arterial disease in diabetic and nondiabetic patients: A comparison of severity and outcome.Diabetes Care.2001; 24(8): 1433-1437, doi: 10.2337/diacare.24.8.1433, indexed in Pubmed: 11473082.
Stone PA, Yacoub M.Inflammatory biomarkers in peripheral arterial disease.Semin Vasc Surg.2014; 27(3-4): 148-151, doi: 10.1053/j.semvascsurg.2015.01.009, indexed in Pubmed: 26073823.
Tzoulaki I, Murray GD, Lee AJ, et al.Inflammatory, haemostatic, and rheological markers for incident peripheral arterial disease: Edinburgh Artery Study.Eur Heart J.2007; 28(3): 354-362, doi: 10.1093/eurheartj/ehl441, indexed in Pubmed: 17213229.
Chuang YW, Yu MC, Lin CL, et al.Risk of peripheral arterial occlusive disease in patients with rheumatoid arthritis.A nationwide population-based cohort study.Thromb Haemost.2016; 115(2): 439-445, doi: 10.1160/TH15-07-0600, indexed in Pubmed: 26446613.
Peeters Weem SMO, van Haelst STW, den Ruijter HM, et al.Lack of Evidence for Dual Antiplatelet Therapy after Endovascular Arterial Procedures: A Meta-analysis.Eur J Vasc Endovasc Surg.2016; 52(2): 253-262, doi: 10.1016/j.ejvs.2016.04.023, indexed in Pubmed: 27241270.
Mousa AY, Broce M, Campbell J, et al.Clopidogrel use before renal artery angioplasty with/without stent placement resulted in tertiary procedure risk reduction.J Vasc Surg.2012; 56(2): 416-423, doi: 10.1016/j.jvs.2012.01.027, indexed in Pubmed: 22560231.
Sacco RL, Kasner SE, Broderick JP, et al.American Heart Association Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Council on Cardiovascular Radiology and Intervention, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, Council on Peripheral Vascular Disease, Council on Nutrition, Physical Activity and Metabolism.An updated definition of stroke for the 21st century: A statement for healthcare professionals from the American Heart Association/American Stroke Association.Stroke.2013; 44(7): 2064-2089, doi: 10.1161/STR.0b013e318296aeca, indexed in Pubmed: 23652265.
Rerkasem K, Bond R, Rothwell PM.Local versus general anaesthesia for carotid endarterectomy.Cochrane Database Syst Rev.2004(2): CD000126, doi: 10.1002/14651858.CD000126.pub2, indexed in Pubmed: 15106144.
Vaniyapong T, Chongruksut W, Rerkasem K.Local versus general anaesthesia for carotid endarterectomy.Cochrane Database Syst Rev.2013(12): CD000126, doi: 10.1002/14651858.CD000126.pub4, indexed in Pubmed: 24353155.
Cao P, De Rango P, Zannetti S.Eversion vs conventional carotid endarterectomy: A systematic review.Eur J Vasc Endovasc Surg.2002; 23(3): 195-201, doi: 10.1053/ejvs.2001.1560, indexed in Pubmed: 11914004.
Rerkasem K, Rothwell PM.Systematic Review of Randomized Controlled Trials of Patch Angioplasty Versus Primary Closure and Different Types of Patch Materials During Carotid Endarterectomy.Asian J Surg.2011; 34(1): 32-40, doi: 10.1016/s1015- -9584(11)60016-x.
Chongruksut W, Vaniyapong T, Rerkasem K.Routine or selective carotid artery shunting for carotid endarterectomy (and different methods of monitoring in selective shunting).Cochrane Database Syst Rev.2014(6): CD000190, doi: 10.1002/14651858.CD000190.
Doig D, Turner EL, Dobson J, et al.ICSS Investigators.Incidence, impact, and predictors of cranial nerve palsy and haematoma following carotid endarterectomy in the international carotid stenting study.Eur J Vasc Endovasc Surg.2014; 48(5): 498-504, doi: 10.1016/j.ejvs.2014.08.002, indexed in Pubmed: 25344019.
Bond R, Narayan SK, Rothwell PM, et al.European Carotid Surgery Trialists' Collaborative Group.Clinical and radiographic risk factors for operative stroke and death in the European carotid surgery trial.Eur J Vasc Endovasc Surg.2002; 23(2): 108-116, doi: 10.1053/ejvs.2001.1541, indexed in Pubmed: 11863327.
Ferguson GG, Eliasziw M, Barr HW, et al.The North American Symptomatic Carotid Endarterectomy Trial : Surgical results in 1415 patients.Stroke.1999; 30(9): 1751-1758, doi: 10.1161/01.
Touzé E, Trinquart L, Felgueiras R, et al.Carotid Stenting Trialists' Collaboration.A clinical rule (sex, contralateral occlusion, age, and restenosis) to select patients for stenting versus carotid endarterectomy: Systematic review of observational studies with validation in randomized trials.Stroke.2013; 44(12): 3394-3400, doi: 10.1161/STROKEAHA.113.002756, indexed in Pubmed: 24135929.
Holt PJE, Poloniecki JD, Loftus IM, et al.Meta-analysis and systematic review of the relationship between hospital volume and outcome following carotid endarterectomy.Eur J Vasc Endovasc Surg.2007; 33(6): 645-651, doi: 10.1016/j.ejvs.2007.01.014, indexed in Pubmed: 17400005.
AbuRahma AF, Stone PA, Srivastava M, et al.The effect of surgeon's specialty and volume on the perioperative outcome of carotid endarterectomy.J Vasc Surg.2013; 58(3): 666-672, doi: 10.1016/j.jvs.2013.02.016, indexed in Pubmed: 23601827.
Macdonald S, Lee R, Williams R, et al.Delphi Carotid Stenting Consensus Panel.Towards safer carotid artery stenting: A scoring system for anatomic suitability.Stroke.2009; 40(5): 1698-1703, doi: 10.1161/STROKEAHA.109.547117, indexed in Pubmed: 19299627.
Ederle J, Dobson J, Featherstone RL, et al.International Carotid Stenting Study investigators.Carotid artery stenting compared with endarterectomy in patients with symptomatic carotid stenosis (International Carotid Stenting Study): An interim analysis of a randomised controlled trial.Lancet.2010; 375(9719): 985-997, doi: 10.1016/S0140-6736(10)60239-5, indexed in Pubmed: 20189239.
Mas JL, Chatellier G, Beyssen B, et al.EVA-3S Investigators.Endarterectomy versus stenting in patients with symptomatic severe carotid stenosis.N Engl J Med.2006; 355(16): 1660-1671, doi: 10.1056/NEJMoa061752, indexed in Pubmed: 17050890.
Moore WS, Popma JJ, Roubin GS, et al.CREST Investigators.Carotid angiographic characteristics in the CREST trial were major contributors to periprocedural stroke and death differences between carotid artery stenting and carotid endarterectomy.J Vasc Surg.2016; 63(4): 851-7, 858.e1, doi: 10.1016/j.jvs.2015.08.119, indexed in Pubmed: 26610643.
Ringleb PA, Allenberg J, Brückmann H, et al.SPACE Collaborative Group.30 day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: A randomised non-inferiority trial.Lancet.2006; 368(9543): 1239-1247, doi: 10.1016/S0140-6736(06)69122-8, indexed in Pubmed: 17027729.
Silver FL, Mackey A, Clark WM, et al.CREST Investigators.Safety of stenting and endarterectomy by symptomatic status in the Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST).Stroke.2011; 42(3): 675-680, doi: 10.1161/STROKEAHA.110.610212, indexed in Pubmed: 21307169.
Gray WA, Rosenfield KA, Jaff MR, et al.CAPTURE 2 Investigators and Executive Committee.Influence of site and operator characteristics on carotid artery stent outcomes: Analysis of the CAPTURE 2 (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events) clinical study.JACC Cardiovasc Interv.2011; 4(2): 235-246, doi: 10.1016/j.jcin.2010.10.009, indexed in Pubmed: 21349464.
Nallamothu BK, Gurm HS, Ting HH, et al.Operator experience and carotid stenting outcomes in Medicare beneficiaries.JAMA.2011; 306(12): 1338-1343, doi: 10.1001/jama.2011.1357, indexed in Pubmed: 21954477.
Roffi M, Sievert H, Gray WA, et al.Carotid artery stenting versus surgery: Adequate comparisons? Lancet Neurol.2010; 9(4): 339-41; author reply 341, doi: 10.1016/S1474-4422(10)70027-2, indexed in Pubmed: 20189459.
Calvet D, Mas JL, Algra A, et al.Carotid Stenting Trialists' Collaboration.Carotid stenting: Is there an operator effect? A pooled analysis from the carotid stenting trialists' collaboration.Stroke.2014; 45(2): 527-532, doi: 10.1161/STROKEAHA.113.003526, indexed in Pubmed: 24347422.
Dua A, Romanelli M, Upchurch GR, et al.Predictors of poor outcome after carotid intervention.J Vasc Surg.2016; 64(3): 663-670, doi: 10.1016/j.jvs.2016.03.428, indexed in Pubmed: 27209401.
Kakkos SK, Sabetai M, Tegos T, et al.Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group.Silent embolic infarcts on computed tomography brain scans and risk of ipsilateral hemispheric events in patients with asymptomatic internal carotid artery stenosis.J Vasc Surg.2009; 49(4): 902-909, doi: 10.1016/j.jvs.2008.10.059, indexed in Pubmed: 19223148.
Kakkos SK, Nicolaides AN, Charalambous I, et al.Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group.Predictors and clinical significance of progression or regression of asymptomatic carotid stenosis.J Vasc Surg.2014; 59(4): 956-967.
Hirt LS.Progression rate and ipsilateral neurological events in asymptomatic carotid stenosis.Stroke.2014; 45(3): 702-706, doi: 10.1161/STROKEAHA.111.613711, indexed in Pubmed: 21799164.
Nicolaides AN, Kakkos SK, Kyriacou E, et al.Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group.Asymptomatic internal carotid artery stenosis and cerebrovascular risk stratification.J Vasc Surg.2010; 52(6): 1486-1496.e1, doi: 10.1016/j.jvs.2010.07.021, indexed in Pubmed: 21146746.
Kakkos SK, Griffin MB, Nicolaides AN, et al.Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group.The size of juxtaluminal hypoechoic area in ultrasound images of asymptomatic carotid plaques predicts the occurrence of stroke.J Vasc Surg.2013; 57(3): 609-618.e1; discussion 617, doi: 10.1016/j.jvs.2012.09.045, indexed in Pubmed: 23337294.
Gupta A, Baradaran H, Schweitzer AD, et al.Carotid plaque MRI and stroke risk: A systematic review and meta-analysis.Stroke.2013; 44(11): 3071-3077, doi: 10.1161/STROKEAHA.113.002551, indexed in Pubmed: 23988640.
King A, Serena J, Bornstein NM, et al.ACES Investigators.Does impaired cerebrovascular reactivity predict stroke risk in asymptomatic carotid stenosis? A prospective substudy of the asymptomatic carotid emboli study.Stroke.2011; 42(6): 1550-1555, doi: 10.1161/STROKEAHA.110.609057, indexed in Pubmed: 21527764.
Gupta A, Kesavabhotla K, Baradaran H, et al.Plaque echolucency and stroke risk in asymptomatic carotid stenosis: A systematic review and meta-analysis.Stroke.2015; 46(1): 91-97, doi: 10.1161/STROKEAHA.114.006091, indexed in Pubmed: 25406150.
Markus HS, King A, Shipley M, et al.Asymptomatic embolisation for prediction of stroke in the Asymptomatic Carotid Emboli Study (ACES): A prospective observational study.Lancet Neurol.2010; 9(7): 663-671, doi: 10.1016/S1474-4422(10)70120-4, indexed in Pubmed: 20554250.
Topakian R, King A, Kwon SU, et al.ACES Investigators.Ultrasonic plaque echolucency and emboli signals predict stroke in asymptomatic carotid stenosis.Neurology.2011; 77(8): 751-758, doi: 10.1212/WNL.0b013e31822b00a6, indexed in Pubmed: 21849657.
Nicolaides AN, Kakkos SK, Griffin M, et al.Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group.Severity of asymptomatic carotid stenosis and risk of ipsilateral hemispheric ischaemic events: Results from the ACSRS study.Eur J Vasc Endovasc Surg.2005; 30(3): 275-284, doi: 10.1016/j.ejvs.2005.04.031, indexed in Pubmed: 16130207.
Brooks WH, McClure RR, Jones MR, et al.Carotid angio- plasty and stenting versus carotid endarterectomy for treatment of asymptomatic carotid stenosis: A randomized trial in a community hospital.Neurosurgery.2004; 54: 318-324.
Hill MD, Brooks W, Mackey A, et al.CREST Investigators, CREST Investigators.Stroke after carotid stenting and endarterectomy in the Carotid Revascularization Endarterectomy versus Stenting Trial (CREST).Circulation.2012; 126(25): 3054-3061, doi: 10.1161/CIRCULATIONAHA.112.120030, indexed in Pubmed: 23159552.
Rosenfield K, Matsumura JS, Chaturvedi S, et al.ACT I Investigators.Randomized Trial of Stent versus Surgery for Asymptomatic Carotid Stenosis.N Engl J Med.2016; 374(11): 1011-1020, doi: 10.1056/NEJMoa1515706, indexed in Pubmed: 26886419.
Eckstein HH, Reiff T, Ringleb P, et al.SPACE 2 Investigators.SPACE- 2: A Missed Opportunity to Compare Carotid Endarterectomy, Carotid Stenting, and Best Medical Treatment in Patients with Asymptomatic Carotid Stenoses.Eur J Vasc Endovasc Surg.2016; 51(6): 761-765, doi: 10.1016/j.ejvs.2016.02.005, indexed in Pubmed: 27085660.
Mannheim D, Karmeli RA.Prospective randomized trial comparing endarterec- tomy to stenting in severe asymptomatic carotid stenosis.J Cardiovasc Surg.2016.
Brott TG, Hobson RW, Howard G, et al.CREST Investigators.Stenting versus endarterectomy for treatment of carotid-artery stenosis.N Engl J Med.2010; 363(1): 11-23, doi: 10.1056/NEJMoa0912321, indexed in Pubmed: 20505173.
Mas JL, Chatellier G, Beyssen B, et al.EVA-3S Investigators.Carotid angioplasty and stenting with and without cerebral protection: Clinical alert from the Endarterectomy Versus Angioplasty in Patients With Symptomatic Severe Carotid Stenosis (EVA-3S) trial.Stroke.2004; 35(1): E18-e20, doi: 10.1161/01.STR.0000106913.33940.DD, indexed in Pubmed: 14657456.
Howard G, Roubin G, Jansen O, et al.Association between age and risk of stroke or death from carotid endarterectomy and carotid stenting: A meta-analysis of pooled patient data from four randomised trials.Lancet.2016; 387(10025): 1305-1311, doi: 10.1016/s0140-6736(15)01309-4.
Borhani Haghighi A, Edgell RC, Cruz-Flores S, et al.Vertebral artery origin stenosis and its treatment.J Stroke Cerebrovasc Dis.2011; 20(4): 369-376, doi: 10.1016/j.jstrokecerebrovasdis.2011.05.007, indexed in Pubmed: 21729790.
Gulli G, Marquardt L, Rothwell PM, et al.Stroke risk after posterior circulation stroke/transient ischemic attack and its relationship to site of vertebrobasilar stenosis: Pooled data analysis from prospective studies.Stroke.2013; 44(3): 598-604, doi: 10.1161/STROKEAHA.112.669929, indexed in Pubmed: 23386676.
Clark CE, Taylor RS, Shore AC, et al.Association of a difference in systolic blood pressure between arms with vascular disease and mortality: A systematic review and meta-analysis.Lancet.2012; 379(9819): 905-914, doi: 10.1016/S0140-6736(11)61710-8, indexed in Pubmed: 22293369.
Labropoulos N, Nandivada P, Bekelis K.Prevalence and impact of the subclavian steal syndrome.Ann Surg.2010; 252(1): 166-170, doi: 10.1097/SLA.0b013e3181e3375a, indexed in Pubmed: 20531004.
Puttarajappa C, Rajan DS.Images in clinical medicine.Allen's test.N Engl J Med.2010; 363(14): E20, doi: 10.1056/NEJMicm1001091, indexed in Pubmed: 20886676.
Björck M, Koelemay M, Acosta S, et al.Editor's Choice - Management of the Diseases of Mesenteric Arteries and Veins: Clinical Practice Guidelines of the European Society of Vascular Surgery (ESVS).Eur J Vasc Endovasc Surg.2017; 53(4): 460-510, doi: 10.1016/j.ejvs.2017.01.010, indexed in Pubmed: 28359440.
Caps MT, Perissinotto C, Zierler RE, et al.Prospective study of atherosclerotic disease progression in the renal artery.Circulation.1998; 98(25): 2866-2872, doi: 10.1161/01.cir.98.25.2866, indexed in Pubmed: 9860789.
Jennings CG, Houston JG, Severn A, et al.Renal artery stenosis- -when to screen, what to stent? Curr Atheroscler Rep.2014; 16(6): 416, doi: 10.1007/s11883-014-0416-2, indexed in Pubmed: 24743868.
Connolly JO, Higgins RM, Walters HL, et al.Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease.QJM.1994; 87(7): 413-421, doi: 10.1093/oxfordjournals.qjmed.a068949, indexed in Pubmed: 7922293.
Tafur-Soto JD, White CJ.Renal artery stenosis.Cardiol Clin.2015; 33(1): 59-73, doi: 10.1016/j.ccl.2014.09.006, indexed in Pubmed: 25439331.
Zeller T, Bonvini RF, Sixt S.Color-coded duplex ultrasound for diagnosis of renal artery stenosis and as follow-up examination after revascularization.Catheter Cardiovasc Interv.2008; 71(7): 995-999, doi: 10.1002/ccd.21525, indexed in Pubmed: 18383154.
Boddi M, Natucci F, Ciani E.The internist and the renal resistive index: Truths and doubts.Intern Emerg Med.2015; 10(8): 893-905, doi: 10.1007/s11739-015-1289-2, indexed in Pubmed: 26337967.
Mulè G, Geraci G, Geraci C, et al.The renal resistive index: Is it a misnomer? Intern Emerg Med.2015; 10(8): 889-891, doi: 10.1007/s11739-015-1323-4, indexed in Pubmed: 26404100.
Doi Y, Iwashima Y, Yoshihara F, et al.Renal resistive index and cardiovascular and renal outcomes in essential hypertension.Hypertension.2012; 60(3): 770-777, doi: 10.1161/HYPERTENSIONAHA.112.196717, indexed in Pubmed: 22824987.
Bruno RM, Daghini E, Versari D, et al.Predictive role of renal resistive index for clinical outcome after revascularization in hypertensive patients with atherosclerotic renal artery stenosis: A monocentric observational study.Cardiovasc Ultrasound.2014; 12: 9, doi: 10.1186/1476-7120-12-9, indexed in Pubmed: 24555729.
van de Ven PJ, Kaatee R, Beutler JJ, et al.Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: A randomised trial.Lancet.1999; 353(9149): 282-286, doi: 10.1016/S0140-6736(98)04432-8, indexed in Pubmed: 9929021.
Lederman RJ, Mendelsohn FO, Santos R, et al.Primary renal artery stenting: Characteristics and outcomes after 363 procedures.Am Heart J.2001; 142(2): 314-323, doi: 10.1067/mhj.2001.116958, indexed in Pubmed: 11479472.
Misra S, Thatipelli MR, Howe PW, et al.Preliminary study of the use of drug-eluting stents in atherosclerotic renal artery stenoses 4 mm in diameter or smaller.J Vasc Interv Radiol.2008; 19(6): 833-839, doi: 10.1016/j.jvir.2008.03.017, indexed in Pubmed: 18503896.
Zähringer M, Sapoval M, Pattynama PMT, et al.Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): Angiographic follow-up after 6 months and clinical outcome up to 2 years.J Endovasc Ther.2007; 14(4): 460-468, doi: 10.1177/152660280701400405, indexed in Pubmed: 17696619.
Simone TA, Brooke BS, Goodney PP, et al.Clinical effectiveness of secondary interventions for restenosis after renal artery stenting.J Vasc Surg.2013; 58(3): 687-694, doi: 10.1016/j.jvs.2013.03.009, indexed in Pubmed: 23688626.
Cooper CJ, Haller ST, Colyer W, et al.Embolic protection and platelet inhibition during renal artery stenting.Circulation.2008; 117(21): 2752-2760, doi: 10.1161/CIRCULATIONAHA.107.730259, indexed in Pubmed: 18490527.
Abela R, Ivanova S, Lidder S, et al.An analysis comparing open surgical and endovascular treatment of atherosclerotic renal artery stenosis.Eur J Vasc Endovasc Surg.2009; 38(6): 666-675, doi: 10.1016/j.ejvs.2009.08.002, indexed in Pubmed: 19726208.
Balzer KM, Pfeiffer T, Rossbach S, et al.Prospective randomized trial of operative vs interventional treatment for renal artery ostial occlusive disease (RAOOD).J Vasc Surg.2009; 49(3): 667-74; discussion 674, doi: 10.1016/j.jvs.2008.10.006, indexed in Pubmed: 19135837.
Duprey A, Chavent B, Meyer-Bisch V, et al.Editor's Choice - Ex vivo Renal Artery Repair with Kidney Autotransplantation for Renal Artery Branch Aneurysms: Long-term Results of Sixty-seven Procedures.Eur J Vasc Endovasc Surg.2016; 51(6): 872-879, doi: 10.1016/j.ejvs.2016.02.017, indexed in Pubmed: 27036374.
Ham SW, Weaver FA.Ex vivo renal artery reconstruction for complex renal artery disease.J Vasc Surg.2014; 60(1): 143-150, doi: 10.1016/j.jvs.2014.01.061, indexed in Pubmed: 24594447.
Cambria RP, Brewster DC, L'Italien GJ, et al.The durability of different recon- structive techniques for atherosclerotic renal artery disease.J Vasc Surg.1994; 20: 76-85.
Novick AC, Ziegelbaum M, Vidt DG, et al.Trends in surgical revascularization for renal artery disease.Ten years' experience.JAMA.1987; 257(4): 498-501, doi: 10.1001/jama.1987.03390040114028, indexed in Pubmed: 3795433.
Senekowitsch C, Assadian A, Wlk MV, et al.Renal artery surgery in the era of endovascular intervention.Vasa.2004; 33(4): 226-230, doi: 10.1024/0301-1526.33.4.226, indexed in Pubmed: 15623198.
Barba A, Estallo L, Rodríguez L, et al.Detection of abdominal aortic aneurysm in patients with peripheral artery disease.Eur J Vasc Endovasc Surg.2005; 30(5): 504-508, doi: 10.1016/j.ejvs.2005.05.011, indexed in Pubmed: 15963741.
Quong WL, Fung ATH, Yu RY, et al.Reassessing the normal toe- -brachial index in young healthy adults.J Vasc Surg.2016; 63(3): 652-656, doi: 10.1016/j.jvs.2015.09.019, indexed in Pubmed: 26916582.
Tehan PE, Santos D, Chuter VH.A systematic review of the sensitivity and specificity of the toe-brachial index for detecting peripheral artery disease.Vasc Med.2016; 21(4): 382-389, doi: 10.1177/1358863X16645854, indexed in Pubmed: 27165712.
Bagger JP, Helligsoe P, Randsbaek F, et al.Effect of verapamil in intermittent claudication A randomized, double-blind, placebo- -controlled, cross-over study after individual dose-response assessment.Circulation.1997; 95(2): 411-414, doi: 10.1161/01.
Gargiulo G, Giugliano G, Brevetti L, et al.Use of statins in lower extremity artery disease: A review.BMC Surg.2012; 12 Suppl 1: S15, doi: 10.1186/1471-2482-12-S1-S15, indexed in Pubmed: 23173874.
Momsen AH, Jensen MB, Norager CB, et al.Drug therapy for improving walking distance in intermittent claudication: A systematic review and meta-analysis of robust randomised controlled studies.Eur J Vasc Endovasc Surg.2009; 38(4): 463-474, doi: 10.1016/j.ejvs.2009.06.002, indexed in Pubmed: 19586783.
Bedenis R, Stewart M, Cleanthis M, et al.Cilostazol for intermittent claudication.Cochrane Database Syst Rev.2014(10): CD003748, doi: 10.1002/14651858.CD003748.pub4, indexed in Pubmed: 25358850.
Hiatt WR, Money SR, Brass EP.Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects).J Vasc Surg.2008; 47(2): 330-336, doi: 10.1016/j.jvs.2007.10.009, indexed in Pubmed: 18155871.
Stevens JW, Simpson E, Harnan S, et al.Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication.Br J Surg.2012; 99(12): 1630-1638, doi: 10.1002/bjs.8895, indexed in Pubmed: 23034699.
Iida O, Yokoi H, Soga Y, et al.STOP-IC investigators.Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol study.Circulation.2013; 127(23): 2307-2315, doi: 10.1161/CIRCULATIONAHA.112.000711, indexed in Pubmed: 23652861.
de Backer T, Stichele RV, Lehert P, et al.Naftidrofuryl for intermittent claudication.Cochrane Database Syst Rev.2008; 2: CD001368.
Boccalon H, Lehert P, Mosnier M.[Effect of naftidrofuryl on physiological walking distance in patients with intermittent claudication].Ann Cardiol Angeiol (Paris).2001; 50(3): 175-182, doi: 10.1016/s0003-3928(01)00016-6, indexed in Pubmed: 12555510.
Nicolaï S, Kruidenier L, Bendermacher B, et al.Ginkgo biloba for intermittent claudication.Cochrane Database Syst Rev.2013; 6: CD006888, doi: 10.1002/14651858.cd006888.pub3.
Robertson L, Andras A.Prostanoids for intermittent claudication.Cochrane Database Syst Rev.2013(4): CD000986, doi: 10.1002/14651858.CD000986.pub3, indexed in Pubmed: 23633305.
Salhiyyah K, Senanayake E, Abdel-Hadi M, et al.Pentoxifylline for intermittent claudication.Cochrane Database Syst Rev.2012; 1: CD005262, doi: 10.1002/14651858.CD005262.pub2, indexed in Pubmed: 22258961.
Sumpio BE, Forsythe RO, Ziegler KR, et al.Clinical implications of the angiosome model in peripheral vascular disease.J Vasc Surg.2013; 58(3): 814-826, doi: 10.1016/j.jvs.2013.06.056, indexed in Pubmed: 23972249.
Bergan JJ, Veith FJ, Bernhard VM, et al.Randomization of autogenous vein and polytetrafluorethylene grafts in femoral-distal reconstruction.Surgery.1982; 92(6): 921-930, indexed in Pubmed: 6755789.
Biancari F, Juvonen T.Angiosome-targeted lower limb revascularization for ischemic foot wounds: Systematic review and meta- -analysis.Eur J Vasc Endovasc Surg.2014; 47(5): 517-522, doi: 10.1016/j.ejvs.2013.12.010, indexed in Pubmed: 24491282.
Bosanquet DC, Glasbey J, Williams IM, et al.Systematic Review and Meta-analysis of Direct Versus Indirect Angiosomal Revascularisation of Infrapopliteal Arteries.Eur J Vasc Endovasc Surg.2014; 48(1): 88-97, doi: 10.1016/j.ejvs.2014.04.002.
Rashid H, Slim H, Zayed H, et al.The impact of arterial pedal arch quality and angiosome revascularization on foot tissue loss healing and infrapopliteal bypass outcome.J Vasc Surg.2013; 57(5): 1219-1226, doi: 10.1016/j.jvs.2012.10.129, indexed in Pubmed: 23523278.
Ubbink DT, Vermeulen H, Ubbink DT, et al.Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia.Cochrane Database Syst Rev.2013; 2: CD004001.
Belch J, Hiatt WR, Baumgartner I, et al.TAMARIS Committees and Investigators.Effect of fibroblast growth factor NV1FGF on amputation and death: A randomised placebo-controlled trial of gene therapy in critical limb ischaemia.Lancet.2011; 377(9781): 1929-1937, doi: 10.1016/S0140-6736(11)60394-2, indexed in Pubmed: 21621834.
Moazzami K, Moazzami B, Roohi A, et al.Local intramuscular transplantation of autologous mononuclear cells for critical lower limb ischaemia.Cochrane Database Syst Rev.2014(12): CD008347, doi: 10.1002/14651858.CD008347.pub3, indexed in Pubmed: 25525690.
Grossman PM, Mendelsohn F, Henry TD, et al.Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.Am Heart J.2007; 153(5): 874-880, doi: 10.1016/j.ahj.2007.01.038, indexed in Pubmed: 17452167.
Nikol S, Baumgartner I, Van Belle E, et al.TALISMAN 201 investigators.Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia.Mol Ther.2008; 16(5): 972-978, doi: 10.1038/mt.2008.33, indexed in Pubmed: 18388929.
Rajagopalan S, Mohler ER, Lederman RJ, et al.Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: A phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.Circulation.2003; 108(16): 1933-1938, doi: 10.1161/01.CIR.0000093398.16124.29, indexed in Pubmed: 14504183.
Teraa M, Sprengers RW, van der Graaf Y, et al.Autologous bone marrow-derived cell therapy in patients with critical limb ischemia: A meta-analysis of randomized controlled clinical trials.Ann Surg.2013; 258(6): 922-929, doi: 10.1097/SLA.0b013e3182854cf1, indexed in Pubmed: 23426345.
Flory CM.Arterial Occlusions Produced by Emboli from Eroded Aortic Atheromatous Plaques.Am J Pathol.1945; 21(3): 549-565, indexed in Pubmed: 19970827.
Hoye SJ, Teitelbaum S, Gore I, et al.Atheromatous embolization; a factor in peripheral gangrene.N Engl J Med.1959; 261(3): 128-131, doi: 10.1056/NEJM195907162610305, indexed in Pubmed: 13666992.
Karmody AM, Powers SR, Monaco VJ, et al."Blue toe" syndrome.An in- dication for limb salvage surgery.Arch Surg.1976; 111(11): 1263-1268, doi: 10.1001/archsurg.1976.01360290097015, indexed in Pubmed: 985075.
Applebaum RM, Kronzon I.Evaluation and management of cholesterol embolization and the blue toe syndrome.Curr Opin Cardiol.1996; 11(5): 533-542, doi: 10.1097/00001573-199609000-00013, indexed in Pubmed: 8889381.
Fisher DF, Clagett GP, Brigham RA, et al.Dilemmas in dealing with the blue toe syndrome: Aortic versus peripheral source.Am J Surg.1984; 148(6): 836-839, indexed in Pubmed: 6507759.
Friedman SG, Krishnasastry KV.External iliac ligation and axillary- bifemoral bypass for blue toe syndrome.Surgery.1994; 115(1): 27-30, indexed in Pubmed: 8284757.
Jenkins DM, Newton WD.Atheroembolism.Am Surg.1991; 57(9): 588-590, indexed in Pubmed: 1929003.
Kaufman J, Shah DM, Leather RP, et al.Atheroembolism and microthromboembolic syndromes: Blue toe syndrome and disseminated atheroembolism.In: RB Rutherford, ed.Vascular Surgery, 4th ed.Philadelphia: WB Saunders.; 1995: 669-677.
McFarland RJ, Taylor RS, Woodyer AB, et al.The femoropopliteal segment as a source of peripheral atheroembolism.J Cardiovasc Surg (Torino).1989; 30(4): 597-603, indexed in Pubmed: 2777867.
O'Keeffe ST, Woods BO, Breslin DJ, et al.Blue toe syndrome.Causes and management.Arch Intern Med.1992; 152(11): 2197-2202, doi: 10.1001/archinte.1992.00400230023004, indexed in Pubmed: 1444678.
Preston FE, Emmanuel IG, Winfield DA, et al.Essential thrombocythaemia and peripheral gangrene.Br Med J.1974; 3(5930): 548-552, doi: 10.1136/bmj.3.5930.548, indexed in Pubmed: 4472103.
Sharma PV, Babu SC, Shah PM, et al.Changing patterns of atheroembolism.Cardiovasc Surg.1996; 4(5): 573-579, doi: 10.1016/0967- 2109(96)00003-8, indexed in Pubmed: 8909813.
Wingo JP, Nix ML, Greenfield LJ, et al.The blue toe syndrome: Hemodynamics and therapeutic correlates of outcome.J Vasc Surg.1986; 3(3): 475-480, doi: 10.1067/mva.1986.avs0030475, indexed in Pubmed: 3512857.
Brewer ML, Kinnison ML, Perler BA, et al.Blue toe syndrome: Treatment with anticoagulants and delayed percutaneous transluminal angioplasty.Radiology.1988; 166(1 Pt 1): 31-36, doi: 10.1148/radiology.166.1.2962224, indexed in Pubmed: 2962224.
Clugston RA, Eisenhauer AC, Matthews RV.Atherectomy of the distal aorta using a "kissing-balloon" technique for the treatment of blue toe syndrome.AJR Am J Roentgenol.1992; 159(1): 125-127, doi: 10.2214/ajr.159.1.1535174, indexed in Pubmed: 1535174.
Dolmatch BL, Rholl KS, Moskowitz LB, et al.Blue toe syndrome: Treatment with percutaneous atherectomy.Radiology.1989; 173(3): 799-804, doi: 10.1148/radiology.173.3.2813788, indexed in Pubmed: 2813788.
el Ashmaoui A, Do DD, Triller J, et al.Angioplasty of the terminal aorta: Follow-up of 20 patients treated by PTA or PTA with stents.Eur J Radiol.1991; 13(2): 113-117, doi: 10.1016/0720- 048x(91)90091-9, indexed in Pubmed: 1835929.
Kumpe DA, Zwerdlinger S, Griffin DJ.Blue digit syndrome: Treatment with percutaneous transluminal angioplasty.Radiology.1988; 166(1 Pt 1): 37-44, doi: 10.1148/radiology.166.1.2962225, indexed in Pubmed: 2962225.
Benvegna S, Cassina I, Giuntini G, et al.Atherothrombotic microembolism of the lower extremities (the blue toe syndrome) from atherosclerotic non-aneurysmal aortic plaques.J Cardiovasc Surg (Torino).1990; 31(1): 87-91, indexed in Pubmed: 2324190.
Brenowitz JB, Gregory J, Edwards WS.Diagnosis and treatment of peripheral atheromatous emboli.J Cardiovasc Surg (Torino).1978; 19(5): 499-502, indexed in Pubmed: 711817.
Bruns FJ, Segel DP, Adler S.Control of cholesterol embolization by discontinuation of anticoagulant therapy.Am J Med Sci.1978; 275(1): 105-108, doi: 10.1097/00000441-197801000-00013, indexed in Pubmed: 665707.
Feder W, Auerbach R."Purple toes": An uncommon sequela of oral coumarin drug therapy.Ann Intern Med.1961; 55: 911-917, doi: 10.7326/0003-4819-55-6-911, indexed in Pubmed: 13891942.
Moldveen-Geronimus M, Merriam JC.Cholesterol Embolization: From Pathological Curiosity to Clinical Entity.Circulation.1967; 35(5): 946-953, doi: 10.1161/01.cir.35.5.946.
Roberts B, Rosato FE, Rosato EF.Heparin-A cause of arterial emboli? Surgery.1964; 55: 803-808, indexed in Pubmed: 14168000.
Weismann RE, Tobin RW.Arterial embolism occurring during systemic heparin therapy.AMA Arch Surg.1958; 76(2): 219-25; discussion 225, doi: 10.1001/archsurg.1958.01280200041005, indexed in Pubmed: 13497418.
Bosch JL, Hunink MG.Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease.Radiology.1997; 204(1): 87-96, doi: 10.1148/radiology.204.1.9205227, indexed in Pubmed: 9205227.
Kvilekval KH, Yunis JP, Mason RA, et al.After the blue toe: Prognosis of noncardiac arterial embolization in the lower extremities.J Vasc Surg.1993; 17(2): 328-34; discussion 334, doi: 10.1016/0741-5214(93)90418-l, indexed in Pubmed: 8433428.
Murphy KD, Encarnacion CE, Le VA, et al.Iliac artery stent placement with the Palmaz stent: Follow-up study.J Vasc Interv Radiol.1995; 6(3): 321-329, doi: 10.1016/s1051-0443(95)72815-9, indexed in Pubmed: 7647431.
Matchett WJ, McFarland DR, Eidt JF, et al.Blue toe syndrome: Treatment with intra-arterial stents and review of therapies.J Vasc Interv Radiol.2000; 11(5): 585-592, doi: 10.1016/s1051- 0443(07)61610-8, indexed in Pubmed: 10834489.
Naylor AR, Mehta Z, Rothwell PM, et al.Carotid artery disease and stroke during coronary artery bypass: A critical review of the literature.Eur J Vasc Endovasc Surg.2002; 23(4): 283-294, doi: 10.1053/ejvs.2002.1609, indexed in Pubmed: 11991687.
Paraskevas KI, Nduwayo S, Saratzis A, et al.Synchronous/staged carotid stenting and coronary bypass surgery: An updated systematic review and meta-analysis.Eur J Vasc Endovasc Surg.2017; 53: 309-319.
Aboyans V, Lacroix P.Indications for carotid screening in patients with coronary artery disease.Presse Med.2009; 38(6): 977-986, doi: 10.1016/j.lpm.2009.02.015, indexed in Pubmed: 19376684.
Steinvil A, Sadeh B, Arbel Y, et al.Prevalence and predictors of concomitant carotid and coronary artery atherosclerotic disease.J Am Coll Cardiol.2011; 57(7): 779-783, doi: 10.1016/j.jacc.2010.09.047, indexed in Pubmed: 21310312.
Sirimarco G, Amarenco P, Labreuche J, et al.Carotid Atherosclerosis and Risk of Subsequent Coronary Event in Outpatients With Atherothrombosis.Stroke.2013; 44(2): 373-379, doi: 10.1161/strokeaha.112.673129.
Cohen MG, Pascua JA, Garcia-Ben M, et al.A simple prediction rule for significant renal artery stenosis in patients undergoing cardiac catheterization.Am Heart J.2005; 150(6): 1204-1211, doi: 10.1016/j.ahj.2005.02.019, indexed in Pubmed: 16338259.
Aboyans V, Tanguy B, Desormais I, et al.Prevalence of renal artery disease and its prognostic significance in patients undergoing coronary bypass grafting.Am J Cardiol.2014; 114(7): 1029-1034, doi: 10.1016/j.amjcard.2014.07.011, indexed in Pubmed: 25150754.
Lee Y, Shin JH, Park HC, et al.A prediction model for renal artery stenosis using carotid ultrasonography measurements in patients undergoing coronary angiography.BMC Nephrol.2014; 15: 60, doi: 10.1186/1471-2369-15-60, indexed in Pubmed: 24731296.
Conlon PJ, Little MA, Pieper K, et al.Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography.Kidney Int.2001; 60(4): 1490-1497, doi: 10.1046/j.1523- -1755.2001.00953.x, indexed in Pubmed: 11576364.
Ahmed B, Al-Khaffaf H.Prevalence of significant asymptomatic carotid artery disease in patients with peripheral vascular disease: A meta-analysis.Eur J Vasc Endovasc Surg.2009; 37(3): 262-271, doi: 10.1016/j.ejvs.2008.10.017, indexed in Pubmed: 19058982.
Aboyans V, Desormais I, Magne J, et al.Renal Artery Stenosis in Patients with Peripheral Artery Disease: Prevalence, Risk Factors and Long-term Prognosis.Eur J Vasc Endovasc Surg.2017; 53(3): 380-385, doi: 10.1016/j.ejvs.2016.10.029, indexed in Pubmed: 27919610.
Amighi J, Schlager O, Haumer M, et al.Renal artery stenosis predicts adverse cardiovascular and renal outcome in patients with peripheral artery disease.Eur J Clin Invest.2009; 39(9): 784-792, doi: 10.1111/j.1365-2362.2009.02180.x, indexed in Pubmed: 19522837.
Kelly R, Staines A, MacWalter R, et al.The prevalence of treatable left ventricular systolic dysfunction in patients who present with noncardiac vascular episodes: A case-control study.J Am Coll Cardiol.2002; 39(2): 219-224, doi: 10.1016/s0735-1097(01)01725-9, indexed in Pubmed: 11788210.
Ward RP, Goonewardena SN, Lammertin G, et al.Comparison of the frequency of abnormal cardiac findings by echocardiography in patients with and without peripheral arterial disease.Am J Cardiol.2007; 99(4): 499-503, doi: 10.1016/j.amjcard.2006.09.102, indexed in Pubmed: 17293193.
Hedberg P, Hammar C, Selmeryd J, et al.Left ventricular systolic dysfunction in outpatients with peripheral atherosclerotic vascular disease: Prevalence and association with location of arterial disease.Eur J Heart Fail.2014; 16(6): 625-632, doi: 10.1002/ejhf.95, indexed in Pubmed: 24771615.
Rizvi S, Kamran H, Salciccioli L, et al.Relation of the ankle brachial index to left ventricular ejection fraction.Am J Cardiol.2010; 105(1): 129-132, doi: 10.1016/j.amjcard.2009.08.664, indexed in Pubmed: 20102904.
Newman AB, Shemanski L, Manolio TA, et al.Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study.The Cardiovascular Health Study Group.Arterioscler Thromb Vasc Biol.1999; 19(3): 538-545, doi: 10.1161/01.atv.19.3.538, indexed in Pubmed: 10073955.
Aronow WS, Ahmed MI, Ekundayo OJ, et al.A propensity-matched study of the association of peripheral arterial disease with cardiovascular outcomes in community-dwelling older adults.Am J Cardiol.2009; 103(1): 130-135, doi: 10.1016/j.amjcard.2008.08.037, indexed in Pubmed: 19101243.
Ostergren J, Sleight P, Dagenais G, et al.HOPE study investigators.Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease.Eur Heart J.2004; 25(1): 17-24, doi: 10.1016/j.ehj.2003.10.033, indexed in Pubmed: 14683738.
Gupta DK, Skali H, Claggett B, et al.Heart failure risk across the spectrum of ankle-brachial index: The ARIC study (Atherosclerosis Risk In Communities).JACC Heart Fail.2014; 2(5): 447-454, doi: 10.1016/j.jchf.2014.05.008, indexed in Pubmed: 25194293.
